SBRA Pengajuan SEC - Sabra Health Care REIT, Inc.- Laporan Tahunan, Pernyataan Kuasa, Prospektus

Mga Batayang Estadistika

LEI	549300E3BC7GU7TAZ621
CIK	1492298

SEC Filings

All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis. These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Sabra Health Care REIT, Inc.

SEC Filings (Chronological Order)

Halaman ini menyediakan daftar lengkap dan kronologis dari Pengajuan SEC, tidak termasuk pengajuan kepemilikan yang kami sediakan di tempat lain.

August 5, 2025	EX-FILING FEES	Security Type Calculation of Filing Fee Tables S-3 Sabra Health Care REIT, Inc. Table 1: Newly Registered and Carry Forward Securities ☐Not Applicable Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Carry Forward Form Type Carry Forward File Number Carry Forwar
August 5, 2025	EX-22.1	The following subsidiary of Sabra Health Care REIT, Inc. (the “Company”) will be the issuer of debt securities under the indenture among the Company, as guarantor, Computershare Trust Company, National Association (as successor to Wells Fargo Bank, N EX-22.1 EXHIBIT 22.1 The following subsidiary of Sabra Health Care REIT, Inc. (the “Company”) will be the issuer of debt securities under the indenture among the Company, as guarantor, Computershare Trust Company, National Association (as successor to Wells Fargo Bank, National Association), as trustee and the subsidiary listed below. Subsidiary Jurisdiction Sabra Health Care Limited Partnership D
August 5, 2025	EX-1.1	SABRA HEALTH CARE REIT, INC. $750,000,000 of Shares of Common Stock (par value $0.01 per share) Equity Distribution Agreement EX-1.1 Exhibit 1.1 SABRA HEALTH CARE REIT, INC. $750,000,000 of Shares of Common Stock (par value $0.01 per share) Equity Distribution Agreement August 5, 2025 Barclays Capital Inc. 745 Seventh Avenue New York, New York 10019 BMO Capital Markets Corp. 151 W 42nd Street, 32nd Floor New York, New York 10036 BofA Securities, Inc. One Bryant Park New York, New York 10036 Citigroup Global Markets Inc.
August 5, 2025	424B5	$750,000,000 Sabra Health Care REIT, Inc. Common Stock 424B5 Table of Contents Filed Pursuant to Rule 424(b)(5) Registration No. 333-289246 PROSPECTUS SUPPLEMENT (To Prospectus Dated August 5, 2025) $750,000,000 Sabra Health Care REIT, Inc. Common Stock This prospectus supplement relates to our issuance and sale of shares of our common stock, par value $0.01 per share, having an aggregate offering price of up to $750,000,000 from time to time through
August 5, 2025	EX-FILING FEES	Security Type Calculation of Filing Fee Tables S-3 Sabra Health Care REIT, Inc. Table 1: Newly Registered and Carry Forward Securities ☐Not Applicable Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Carry Forward Form Type Carry Forward File Number Carry Forwar
August 5, 2025	EX-25.1	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM T-1 STATEMENT OF ELIGIBILITY UNDER THE TRUST INDENTURE ACT OF 1939 OF A CORPORATION DESIGNATED TO ACT AS TRUSTEE EX-25.1 Exhibit 25.1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM T-1 STATEMENT OF ELIGIBILITY UNDER THE TRUST INDENTURE ACT OF 1939 OF A CORPORATION DESIGNATED TO ACT AS TRUSTEE ☐ CHECK IF AN APPLICATION TO DETERMINE ELIGIBILITY OF A TRUSTEE PURSUANT TO SECTION 305(b)(2) COMPUTERSHARE TRUST COMPANY, NATIONAL ASSOCIATION (Exact name of trustee as specified in its ch
August 5, 2025	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 5, 2025 SABRA HEALTH CARE UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 5, 2025 SABRA HEALTH CARE REIT, INC. (Exact Name of Registrant as Specified in Its Charter) Maryland 001-34950 27-2560479 (State of Incorporation) (Commission File Number) (I.R
August 5, 2025	S-3ASR	As filed with the Securities and Exchange Commission on August 5, 2025 S-3ASR Table of Contents As filed with the Securities and Exchange Commission on August 5, 2025 Registration No.
August 4, 2025	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 4, 2025 SABRA HEALTH CARE UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 4, 2025 SABRA HEALTH CARE REIT, INC. (Exact name of registrant as specified in its charter) Maryland 001-34950 27-2560479 (State of Incorporation) (Commission File Number) (I.R
August 4, 2025	EX-99.2	2 SABRA 2Q 2025 SUPPLEMENTAL INFORMATION June 30, 2025 03 COMPANY INFORMATION 04 OVERVIEW 05 PORTFOLIO Triple-Net Portfolio Senior Housing - Managed Portfolio Loans and Other Investments NOI Concentrations Geographic Concentrations - Consolidated Por sbraex9922025q2-final 2 SABRA 2Q 2025 SUPPLEMENTAL INFORMATION June 30, 2025 03 COMPANY INFORMATION 04 OVERVIEW 05 PORTFOLIO Triple-Net Portfolio Senior Housing - Managed Portfolio Loans and Other Investments NOI Concentrations Geographic Concentrations - Consolidated Portfolio Triple-Net Lease Expirations 12 INVESTMENTS Summary 13 CAPITALIZATION Overview Indebtedness Debt Maturity Credit Metrics
August 4, 2025	EX-99.4	Strategic. Disciplined. Opportunistic. Investor Presentation \| August 4, 2025 August 4, 2025 Investor Presentation Forward-Looking Statements This presentation contains “forward-looking” statements as defined in the Private Securities Litigation Refo sbraex9942025q2-final Strategic. Disciplined. Opportunistic. Investor Presentation \| August 4, 2025 August 4, 2025 Investor Presentation Forward-Looking Statements This presentation contains “forward-looking” statements as defined in the Private Securities Litigation Reform Act of 1995. Any statements that do not relate to historical or current facts or matters are forward-looking statements. Thes
August 4, 2025	EX-22.1	List of Subsidiary Issuers and Guarantors of Sabra Health Care REIT, Inc. EXHIBIT 22.1 List of Subsidiary Issuers and Guarantors of Sabra Health Care REIT, Inc. Sabra Health Care Limited Partnership (the “Operating Partnership”), a Delaware limited partnership and subsidiary of Sabra Health Care REIT, Inc. (the “Company”), is the issuer of the following securities registered under the Securities Act of 1933, as amended, for which the Company is the guarantor: (i) $350.0
August 4, 2025	EX-99.3	Reconciliations of Non-GAAP Financial Measures June 30, 2025 SABRA HEALTH CARE REIT, INC. 2025 OUTLOOK Reconciliations of Non-GAAP Financial Measures June 30, 2025 (Unaudited) SABRA HEALTH CARE REIT, INC.
August 4, 2025	EX-99.1	SABRA HEALTH CARE REIT, INC. CONSOLIDATED STATEMENTS OF INCOME (dollars in thousands, except per share data) Three Months Ended June 30, Six Months Ended June 30, 2025 2024 2025 2024 Revenues: Rental and related revenues (1) $ 99,823 $ 99,096 $ 195,8 Exhibit 99.1 FOR IMMEDIATE RELEASE SABRA REPORTS SECOND QUARTER 2025 RESULTS; UPDATES 2025 GUIDANCE TUSTIN, CA, August 4, 2025 — Sabra Health Care REIT, Inc. (“Sabra,” the “Company” or “we”) (Nasdaq: SBRA) today announced its results of operations for the second quarter of 2025. SECOND QUARTER 2025 RESULTS AND RECENT EVENTS •Results per diluted common share for the second quarter of 2025 were as f
August 4, 2025	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001
July 31, 2025	EX-10.1	Credit Agreement, dated July 30, 2025, among Sabra Health Care Limited Partnership and Sabra Canadian Holdings, LLC, as Borrowers; Sabra Health Care REIT, Inc., as a guarantor; the other guarantors party thereto; the lenders party thereto; KeyBank National Association, as Administrative Agent; Bank of America, N.A., Citizens Bank, National Association, Crédit Agricole Corporate and Investment Bank and Wells Fargo Bank, National Association, as Co-Syndication Agents; Truist Bank and Mizuho Bank, Ltd., as Co-Documentation Agents; KeyBanc Capital Markets, Inc., as Joint Lead Arranger and Sole Bookrunner; and Bank of America, N.A., Citizens Bank, National Association, Crédit Agricole Corporate and Investment Bank and Wells Fargo Bank, National Association, as Joint Lead Arrangers. sbraex101 4378364.5 CREDIT AGREEMENT Dated as of July 30, 2025 among SABRA HEALTH CARE LIMITED PARTNERSHIP and SABRA CANADIAN HOLDINGS, LLC, as Borrowers, SABRA HEALTH CARE REIT, INC., and CERTAIN SUBSIDIARIES OF SABRA HEALTH CARE REIT, INC. FROM TIME TO TIME PARTY HERETO, as Guarantors, THE LENDERS PARTY HERETO FROM TIME TO TIME, KEYBANK NATIONAL ASSOCIATION, as Administrative Agent, BANK OF AMER
July 31, 2025	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): July 30, 2025 SABRA HEALTH CARE R UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): July 30, 2025 SABRA HEALTH CARE REIT, INC. (Exact name of registrant as specified in its charter) Maryland 001-34950 27-2560479 (State of Incorporation) (Commission File Number) (I.R.
June 30, 2025	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 30, 2025 SABRA HEALTH CARE R UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 30, 2025 SABRA HEALTH CARE REIT, INC. (Exact name of registrant as specified in its charter) Maryland 001-34950 27-2560479 (State of Incorporation) (Commission File Number) (I.R.
June 12, 2025	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 12, 2025 SABRA HEALTH CARE R UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 12, 2025 SABRA HEALTH CARE REIT, INC. (Exact name of registrant as specified in its charter) Maryland 001-34950 27-2560479 (State of Incorporation) (Commission File Number) (I.R.
May 5, 2025	EX-99.3	Reconciliations of Non-GAAP Financial Measures March 31, 2025 SABRA HEALTH CARE REIT, INC. RECONCILIATIONS OF NON-GAAP FINANCIAL MEASURES FFO, Normalized FFO, AFFO and Normalized AFFO (dollars in thousands, except per share data) Three Months Ended M Reconciliations of Non-GAAP Financial Measures March 31, 2025 (Unaudited) SABRA HEALTH CARE REIT, INC.
May 5, 2025	EX-99.1	SABRA HEALTH CARE REIT, INC. CONSOLIDATED STATEMENTS OF INCOME (dollars in thousands, except per share data) Three Months Ended March 31, 2025 2024 Revenues: Rental and related revenues (1) $ 96,037 $ 91,776 Resident fees and services 77,447 66,031 I Exhibit 99.1 FOR IMMEDIATE RELEASE SABRA REPORTS FIRST QUARTER 2025 RESULTS; REITERATES 2025 GUIDANCE TUSTIN, CA, May 5, 2025 — Sabra Health Care REIT, Inc. (“Sabra,” the “Company” or “we”) (Nasdaq: SBRA) today announced its results of operations for the first quarter of 2025. FIRST QUARTER 2025 RESULTS AND RECENT EVENTS •Results per diluted common share for the first quarter of 2025 were as follo
May 5, 2025	8-K	Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 5, 2025 SABRA HEALTH CARE REIT, INC. (Exact name of registrant as specified in its charter) Maryland 001-34950 27-2560479 (State of Incorporation) (Commission File Number) (I.R.S.
May 5, 2025	EX-10.2	Sabra Health Care REIT, Inc. Directors’ Compensation Policy, effective June 12, 2025. SABRA HEALTH CARE REIT, INC. DIRECTORS’ COMPENSATION POLICY (Effective June 12, 2025) Directors of Sabra Health Care REIT, Inc., a Maryland corporation (the “Company”), who are not employed by the Company or one of its subsidiaries (“non-employee directors”) are entitled to the compensation set forth below for their service as a member of the Board of Directors (the “Board”) of the Company. The Bo
May 5, 2025	EX-99.4	Strategic. Disciplined. Opportunistic. Investor Presentation \| May 5, 2025 May 5, 2025 Investor Presentation Forward-Looking Statements This presentation contains “forward-looking” statements as defined in the Private Securities Litigation Reform Act Strategic. Disciplined. Opportunistic. Investor Presentation \| May 5, 2025 May 5, 2025 Investor Presentation Forward-Looking Statements This presentation contains “forward-looking” statements as defined in the Private Securities Litigation Reform Act of 1995. Any statements that do not relate to historical or current facts or matters are forward-looking statements. These statements may be identifi
May 5, 2025	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 00
May 5, 2025	EX-99.2	2 SABRA 1Q 2025 SUPPLEMENTAL INFORMATION March 31, 2025 03 COMPANY INFORMATION 04 OVERVIEW 05 PORTFOLIO Triple-Net Portfolio Senior Housing - Managed Portfolio Loans and Other Investments NOI Concentrations Geographic Concentrations - Consolidated Po 2 SABRA 1Q 2025 SUPPLEMENTAL INFORMATION March 31, 2025 03 COMPANY INFORMATION 04 OVERVIEW 05 PORTFOLIO Triple-Net Portfolio Senior Housing - Managed Portfolio Loans and Other Investments NOI Concentrations Geographic Concentrations - Consolidated Portfolio Triple-Net Lease Expirations 12 INVESTMENTS Summary 13 CAPITALIZATION Overview Indebtedness Debt Maturity Credit Metrics and Ratings 17 FINANC
April 25, 2025	DEFA14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14
April 25, 2025	DEF 14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14
March 24, 2025	EX-99.1	Sabra Health Care REIT, Inc. Announces Chief Investment Officer Transition Exhibit 99.1 Sabra Health Care REIT, Inc. Announces Chief Investment Officer Transition March 24, 2025 TUSTIN, Calif.-(BUSINESS WIRE)- Sabra Health Care REIT, Inc. (“Sabra”) (Nasdaq: SBRA) today announced that Talya Nevo-Hacohen, Sabra’s Chief Investment Officer, Treasurer and Executive Vice President, has decided to retire effective December 31, 2025 and Darrin Smith, Sabra’s Executive Vice Presi
March 24, 2025	EX-10.1	Consulting Agreement, dated March 20, 2025, by and between Talya Nevo-Hacohen and Sabra Health Care REIT, Inc. Exhibit 10.1 CONSULTING AGREEMENT This Consulting Agreement (“Agreement”), dated as of March 20, 2025, is made and entered into by and between Talya Nevo-Hacohen (“Consultant”) and Sabra Health Care REIT, Inc. (“Company”). WHEREAS, Consultant will be retiring from her position as Chief Investment Officer of the Company effective December 31, 2025; WHEREAS, Company and Consultant desire to enter in
March 24, 2025	8-K	Regulation FD Disclosure, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 20, 2025 SABRA HEALTH CARE REIT, INC. (Exact name of registrant as specified in its charter) Maryland 001-34950 27-2560479 (State of Incorporation) (Commission File Number) (I.R
February 19, 2025	EX-19.1	Sabra Health Care REIT, Inc. Insider Trading Policy, effective December 12, 2024. Exhibit 19.1 SABRA HEALTH CARE REIT, INC. INSIDER TRADING POLICY (As amended, December 12, 2024) 1.Background and Purpose. Sabra Health Care REIT, Inc. (“Sabra”) and all members of the board of directors and employees of Sabra and its subsidiaries are subject to federal and state “insider trading” laws with respect to transactions involving Sabra securities. These laws prohibit (a) purchasing or s
February 19, 2025	EX-21.1	List of Subsidiaries of Sabra Health Care REIT, Inc. Exhibit 21.1 Sabra Subsidiaries Entity Name Jurisdiction of Organization 1717 Senior Partners, LLC Indiana 2100 Benvoulin Court Holdings, Inc. British Columbia 2829-34th Street Holdings, Inc. British Columbia 317 Winnipeg St. Holdings Inc. British Columbia 3211 Alexis Park Drive Holdings Inc. British Columbia 870 Westminster Ave. Holdings, Inc. British Columbia Beaumont Senior Partners, LLC Indian
February 19, 2025	EX-99.2	Exhibit 99.2 2 SABRA 4Q 2024 SUPPLEMENTAL INFORMATION December 31, 2024 03 COMPANY INFORMATION 04 OVERVIEW 05 PORTFOLIO Triple-Net Portfolio Senior Housing - Managed Portfolio Loans and Other Investments NOI Concentrations Geographic Concentrations - Exhibit 99.2 2 SABRA 4Q 2024 SUPPLEMENTAL INFORMATION December 31, 2024 03 COMPANY INFORMATION 04 OVERVIEW 05 PORTFOLIO Triple-Net Portfolio Senior Housing - Managed Portfolio Loans and Other Investments NOI Concentrations Geographic Concentrations - Consolidated Portfolio Triple-Net Lease Expirations 12 INVESTMENTS Summary 13 CAPITALIZATION Overview Indebtedness Debt Maturity Credit Metrics and R
February 19, 2025	EX-99.3	Reconciliations of Non-GAAP Financial Measures December 31, 2024 SABRA HEALTH CARE REIT, INC. 2025 OUTLOOK Reconciliations of Non-GAAP Financial Measures December 31, 2024 (Unaudited) SABRA HEALTH CARE REIT, INC.
February 19, 2025	8-K	Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 19, 2025 SABRA HEALTH CARE REIT, INC. (Exact name of registrant as specified in its charter) Maryland 001-34950 27-2560479 (State of Incorporation) (Commission File Number) (
February 19, 2025	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number 001-34950 SABRA HEALTH CARE REIT, INC. (Exact Name of Regis
February 19, 2025	EX-99.1	SABRA HEALTH CARE REIT, INC. CONSOLIDATED STATEMENTS OF INCOME (dollars in thousands, except per share data) Three Months Ended December 31, Year Ended December 31, 2024 2023 2024 2023 Revenues: Rental and related revenues (1) $ 96,068 $ 93,037 $ 381 Exhibit 99.1 FOR IMMEDIATE RELEASE SABRA REPORTS FOURTH QUARTER 2024 RESULTS; INTRODUCES 2025 GUIDANCE TUSTIN, CA, February 19, 2025 — Sabra Health Care REIT, Inc. (“Sabra,” the “Company” or “we”) (Nasdaq: SBRA) today announced its results of operations for the fourth quarter of 2024. FOURTH QUARTER 2024 RESULTS AND RECENT EVENTS •Results per diluted common share for the fourth quarter of 2024 wer
February 19, 2025	EX-99.4	Strategic. Disciplined. Opportunistic. Investor Presentation \| February 19, 2025 February 19, 2025 Investor Presentation Forward-Looking Statements This presentation contains “forward-looking” statements as defined in the Private Securities Litigatio Strategic. Disciplined. Opportunistic. Investor Presentation \| February 19, 2025 February 19, 2025 Investor Presentation Forward-Looking Statements This presentation contains “forward-looking” statements as defined in the Private Securities Litigation Reform Act of 1995. Any statements that do not relate to historical or current facts or matters are forward-looking statements. These statements may
November 12, 2024	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 7, 2024 SABRA HEALTH CAR UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 7, 2024 SABRA HEALTH CARE REIT, INC. (Exact name of registrant as specified in its charter) Maryland 001-34950 27-2560479 (State of Incorporation) (Commission File Number) (I
October 31, 2024	EX-99.3	Reconciliations of Non-GAAP Financial Measures September 30, 2024 SABRA HEALTH CARE REIT, INC. 2024 OUTLOOK Reconciliations of Non-GAAP Financial Measures September 30, 2024 (Unaudited) SABRA HEALTH CARE REIT, INC.
October 31, 2024	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file numbe
October 31, 2024	EX-99.2	Exhibit 99.2 2 SABRA 3Q 2024 SUPPLEMENTAL INFORMATION September 30, 2024 03 COMPANY INFORMATION 04 OVERVIEW 05 PORTFOLIO Triple-Net Portfolio Senior Housing - Managed Portfolio Loans and Other Investments NOI Concentrations Geographic Concentrations Exhibit 99.2 2 SABRA 3Q 2024 SUPPLEMENTAL INFORMATION September 30, 2024 03 COMPANY INFORMATION 04 OVERVIEW 05 PORTFOLIO Triple-Net Portfolio Senior Housing - Managed Portfolio Loans and Other Investments NOI Concentrations Geographic Concentrations - Consolidated Portfolio Triple-Net Lease Expirations 12 INVESTMENTS Summary 13 CAPITALIZATION Overview Indebtedness Debt Maturity Credit Metrics and
October 31, 2024	EX-99.4	Strategic. Disciplined. Opportunistic. Investor Presentation \| October 31, 2024 October 31, 2024 Investor Presentation Forward-Looking Statements This presentation contains “forward-looking” statements as defined in the Private Securities Litigation Strategic. Disciplined. Opportunistic. Investor Presentation \| October 31, 2024 October 31, 2024 Investor Presentation Forward-Looking Statements This presentation contains “forward-looking” statements as defined in the Private Securities Litigation Reform Act of 1995. Any statements that do not relate to historical or current facts or matters are forward-looking statements. These statements may b
October 31, 2024	8-K	Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 31, 2024 SABRA HEALTH CARE REIT, INC. (Exact name of registrant as specified in its charter) Maryland 001-34950 27-2560479 (State of Incorporation) (Commission File Number) (I
October 31, 2024	EX-99.1	SABRA HEALTH CARE REIT, INC. CONSOLIDATED STATEMENTS OF INCOME (LOSS) (dollars in thousands, except per share data) Three Months Ended September 30, Nine Months Ended September 30, 2024 2023 2024 2023 Revenues: Rental and related revenues (1) $ 94,55 Exhibit 99.1 FOR IMMEDIATE RELEASE SABRA REPORTS THIRD QUARTER 2024 RESULTS; UPDATES 2024 GUIDANCE TUSTIN, CA, October 31, 2024 — Sabra Health Care REIT, Inc. (“Sabra,” the “Company” or “we”) (Nasdaq: SBRA) today announced its results of operations for the third quarter of 2024. THIRD QUARTER 2024 RESULTS AND RECENT EVENTS •Results per diluted common share for the third quarter of 2024 were as fol
October 18, 2024	SC 13G/A	SBRA / Sabra Health Care REIT, Inc. / STATE STREET CORP Passive Investment SC 13G/A 1 SabraHealthCareREITInc.htm SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* SABRA HEALTH CARE REIT INC (Name of Issuer) COMMON STOCK (Title of Class of Securities) 78573L106 (CUSIP Number) September 30, 2024 (Date of Event Which Requires Filing of This Statement) Check the appropriate box to designate the
August 7, 2024	EX-99.1	SABRA HEALTH CARE REIT, INC. CONSOLIDATED STATEMENTS OF INCOME (dollars in thousands, except per share data) Three Months Ended June 30, Six Months Ended June 30, 2024 2023 2024 2023 Revenues: Rental and related revenues (1) $ 99,096 $ 94,274 $ 190,8 Exhibit 99.1 FOR IMMEDIATE RELEASE SABRA REPORTS SECOND QUARTER 2024 RESULTS; INCREASES 2024 GUIDANCE TUSTIN, CA, August 7, 2024 — Sabra Health Care REIT, Inc. (“Sabra,” the “Company” or “we”) (Nasdaq: SBRA) today announced its results of operations for the second quarter of 2024. SECOND QUARTER 2024 RESULTS AND RECENT EVENTS •Results per diluted common share for the second quarter of 2024 were as
August 7, 2024	EX-99.2	Exhibit 99.2 2 SABRA 2Q 2024 SUPPLEMENTAL INFORMATION June 30, 2024 03 COMPANY INFORMATION 04 OVERVIEW 05 PORTFOLIO Triple-Net Portfolio Senior Housing - Managed Portfolio Loans and Other Investments NOI Concentrations Geographic Concentrations - Con sbraex9922024q2-final Exhibit 99.2 2 SABRA 2Q 2024 SUPPLEMENTAL INFORMATION June 30, 2024 03 COMPANY INFORMATION 04 OVERVIEW 05 PORTFOLIO Triple-Net Portfolio Senior Housing - Managed Portfolio Loans and Other Investments NOI Concentrations Geographic Concentrations - Consolidated Portfolio Triple-Net Lease Expirations 12 INVESTMENTS Summary 13 CAPITALIZATION Overview Indebtedness Debt Maturity Cr
August 7, 2024	EX-99.4	Strategic. Disciplined. Opportunistic. Investor Presentation \| August 7, 2024 August 7, 2024 Investor Presentation Forward-Looking Statements This presentation contains “forward-looking” statements as defined in the Private Securities Litigation Refo sbraex9942024q2-final Strategic. Disciplined. Opportunistic. Investor Presentation \| August 7, 2024 August 7, 2024 Investor Presentation Forward-Looking Statements This presentation contains “forward-looking” statements as defined in the Private Securities Litigation Reform Act of 1995. Any statements that do not relate to historical or current facts or matters are forward-looking statements. Thes
August 7, 2024	424B5	$500,000,000 Sabra Health Care REIT, Inc. Common Stock Filed Pursuant to Rule 424(b)(5) Registration No. 333-268285 PROSPECTUS SUPPLEMENT (To Prospectus Supplement dated February 23, 2023 and Prospectus dated November 10, 2022) $500,000,000 Sabra Health Care REIT, Inc. Common Stock This prospectus supplement is being filed to update, amend and supplement certain information in the prospectus supplement dated and filed with the Securities and Exchange
August 7, 2024	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 7, 2024 SABRA HEALTH CARE UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 7, 2024 SABRA HEALTH CARE REIT, INC. (Exact name of registrant as specified in its charter) Maryland 001-34950 27-2560479 (State of Incorporation) (Commission File Number) (I.R
August 7, 2024	EX-99.3	Reconciliations of Non-GAAP Financial Measures June 30, 2024 SABRA HEALTH CARE REIT, INC. 2024 OUTLOOK Reconciliations of Non-GAAP Financial Measures June 30, 2024 (Unaudited) SABRA HEALTH CARE REIT, INC.
August 7, 2024	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001
June 13, 2024	8-K	Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 13, 2024 SABRA HEALTH CARE REIT, INC. (Exact name of registrant as specified in its charter) Maryland 001-34950 27-2560479 (State of Incorporation) (Commission File Number) (I.R.
May 8, 2024	EX-99.3	Reconciliations of Non-GAAP Financial Measures March 31, 2024 SABRA HEALTH CARE REIT, INC. 2024 OUTLOOK Reconciliations of Non-GAAP Financial Measures March 31, 2024 (Unaudited) SABRA HEALTH CARE REIT, INC.
May 8, 2024	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 00
May 8, 2024	EX-99.2	Exhibit 99.2 2 SABRA 1Q 2024 SUPPLEMENTAL INFORMATION March 31, 2024 03 COMPANY INFORMATION 04 OVERVIEW 05 PORTFOLIO Triple-Net Portfolio Senior Housing - Managed Portfolio Loans and Other Investments NOI Concentrations Geographic Concentrations - Co Exhibit 99.2 2 SABRA 1Q 2024 SUPPLEMENTAL INFORMATION March 31, 2024 03 COMPANY INFORMATION 04 OVERVIEW 05 PORTFOLIO Triple-Net Portfolio Senior Housing - Managed Portfolio Loans and Other Investments NOI Concentrations Geographic Concentrations - Consolidated Portfolio Triple-Net Lease Expirations 12 CAPITALIZATION Overview Indebtedness Debt Maturity Credit Metrics and Ratings 16 FINANCIAL INFORM
May 8, 2024	EX-99.4	Strategic. Disciplined. Opportunistic. Investor Presentation \| May 8, 2024 May 8, 2024 Investor Presentation Forward-Looking Statements This presentation contains “forward-looking” statements as defined in the Private Securities Litigation Reform Act Strategic. Disciplined. Opportunistic. Investor Presentation \| May 8, 2024 May 8, 2024 Investor Presentation Forward-Looking Statements This presentation contains “forward-looking” statements as defined in the Private Securities Litigation Reform Act of 1995. Any statements that do not relate to historical or current facts or matters are forward-looking statements. These statements may be identifi
May 8, 2024	8-K	Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 8, 2024 SABRA HEALTH CARE REIT, INC. (Exact name of registrant as specified in its charter) Maryland 001-34950 27-2560479 (State of Incorporation) (Commission File Number) (I.R.S.
May 8, 2024	EX-99.1	SABRA HEALTH CARE REIT, INC. CONSOLIDATED STATEMENTS OF INCOME (LOSS) (dollars in thousands, except per share data) Three Months Ended March 31, 2024 2023 Revenues: Rental and related revenues (1) $ 91,776 $ 95,870 Resident fees and services 66,031 5 Exhibit 99.1 FOR IMMEDIATE RELEASE SABRA REPORTS FIRST QUARTER 2024 RESULTS; REITERATES 2024 GUIDANCE TUSTIN, CA, May 8, 2024 — Sabra Health Care REIT, Inc. (“Sabra,” the “Company” or “we”) (Nasdaq: SBRA) today announced its results of operations for the first quarter of 2024. FIRST QUARTER 2024 RESULTS AND RECENT EVENTS •Results per diluted common share for the first quarter of 2024 were as follo
April 26, 2024	DEFA14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2
April 26, 2024	DEF 14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14
February 27, 2024	EX-99.1	SABRA HEALTH CARE REIT, INC. CONSOLIDATED STATEMENTS OF INCOME (LOSS) (dollars in thousands, except per share data) Three Months Ended December 31, Year Ended December 31, 2023 2022 2023 2022 Revenues: Rental and related revenues (1) $ 93,037 $ 103,3 Exhibit 99.1 FOR IMMEDIATE RELEASE SABRA REPORTS FOURTH QUARTER 2023 RESULTS; INTRODUCES 2024 GUIDANCE TUSTIN, CA, February 27, 2024 — Sabra Health Care REIT, Inc. (“Sabra,” the “Company” or “we”) (Nasdaq: SBRA) today announced its results of operations for the fourth quarter of 2023. FOURTH QUARTER 2023 RESULTS AND RECENT EVENTS •Results per diluted common share for the fourth quarter of 2023 wer
February 27, 2024	EX-21.1	List of Subsidiaries of Sabra Health Care REIT, Inc. Exhibit 21.1 Sabra Subsidiaries Entity Name Jurisdiction of Organization 1717 Senior Partners, LLC Indiana 2100 Benvoulin Court Holdings, Inc. British Columbia 2829-34th Street Holdings, Inc. British Columbia 317 Winnipeg St. Holdings Inc. British Columbia 870 Westminster Ave. Holdings, Inc. British Columbia Arden Real Estate Holdings, LLC Delaware Beaumont Senior Partners, LLC Indiana Beavercreek
February 27, 2024	8-K	Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 27, 2024 SABRA HEALTH CARE REIT, INC. (Exact name of registrant as specified in its charter) Maryland 001-34950 27-2560479 (State of Incorporation) (Commission File Number) (
February 27, 2024	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number 001-34950 SABRA HEALTH CARE REIT, INC. (Exact Name of Regis
February 27, 2024	EX-99.3	Reconciliations of Non-GAAP Financial Measures December 31, 2023 SABRA HEALTH CARE REIT, INC. 2024 OUTLOOK Reconciliations of Non-GAAP Financial Measures December 31, 2023 (Unaudited) SABRA HEALTH CARE REIT, INC.
February 27, 2024	EX-10.9	d by reference to Exhibit 10.9 of the Annual Report on 10-K filed by Sabra Health Care EXHIBIT 10.9 SABRA HEALTH CARE REIT, INC. DIRECTORS’ COMPENSATION POLICY (Effective March 21, 2023) Directors of Sabra Health Care REIT, Inc., a Maryland corporation (the “Company”), who are not employed by the Company or one of its subsidiaries (“non-employee directors”) are entitled to the compensation set forth below for their service as a member of the Board of Directors (the “Board”) of the C
February 27, 2024	EX-99.2	Exhibit 99.2 2 SABRA 4Q 2023 SUPPLEMENTAL INFORMATION December 31, 2023 03 COMPANY INFORMATION 04 OVERVIEW 05 PORTFOLIO Triple-Net Portfolio Top 10 Relationships Senior Housing - Managed Portfolio Loans and Other Investments NOI Concentrations Geogra Exhibit 99.2 2 SABRA 4Q 2023 SUPPLEMENTAL INFORMATION December 31, 2023 03 COMPANY INFORMATION 04 OVERVIEW 05 PORTFOLIO Triple-Net Portfolio Top 10 Relationships Senior Housing - Managed Portfolio Loans and Other Investments NOI Concentrations Geographic Concentrations - Consolidated Portfolio Triple-Net Lease Expirations 13 INVESTMENTS Summary 14 CAPITALIZATION Overview Indebtedness Debt Maturity
February 27, 2024	EX-99.4	Cost Committed to Long-Term Value Investor Presentation \| February 27, 2024 February 27, 2024 Investor Presentation Forward-Looking Statements This presentation contains “forward-looking” statements as defined in the Private Securities Litigation Ref Cost Committed to Long-Term Value Investor Presentation \| February 27, 2024 February 27, 2024 Investor Presentation Forward-Looking Statements This presentation contains “forward-looking” statements as defined in the Private Securities Litigation Reform Act of 1995.
February 27, 2024	EX-97.1	Sabra Health Care REIT, Inc. Incentive Compensation Recoupment Policy, effective September 20, 2023 EXHIBIT 97.1 Incentive Compensation Recoupment Policy As Amended and Restated by the Board of Directors on September 20, 2023 In the event Sabra Health Care REIT, Inc. (the “Company”) is required to prepare an accounting restatement due to the material noncompliance of the Company with any financial reporting requirement under the securities laws (including any required accounting restatement to c
February 13, 2024	SC 13G/A	SBRA / Sabra Health Care REIT, Inc. / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SC 13G/A 1 tv01862-sabrahealthcarereiti.htm SCHEDULE 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 14)* Name of issuer: Sabra Health Care REIT Inc Title of Class of Securities: Common Stock CUSIP Number: 78573L106 Date of Event Which Requires Filing of this Statement: December 29, 2023 Check the appropriate bo
January 4, 2024	EX-99.1	Sabra Health Care REIT Appoints Jessica Flores as Chief Accounting Officer Exhibit 99.1 Sabra Health Care REIT Appoints Jessica Flores as Chief Accounting Officer January 4, 2024 IRVINE, Calif.-(BUSINESS WIRE)- Sabra Health Care REIT, Inc. (“Sabra”) (Nasdaq: SBRA) today announced that Jessica Flores has been appointed Executive Vice President and Chief Accounting Officer and, in such capacity, has been designated by the Company’s Board of Directors as the Company’s princ
January 4, 2024	8-K	Regulation FD Disclosure, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 29, 2023 SABRA HEALTH CARE REIT, INC. (Exact name of registrant as specified in its charter) Maryland 001-34950 27-2560479 (State of Incorporation) (Commission File Number) (
January 4, 2024	EX-10.1	Severance Benefits Agreement, dated January 1, 2024, by and between Jessica Flores and Sabra Health Care REIT, Inc. Exhibit 10.1 SEVERANCE BENEFITS AGREEMENT THIS SEVERANCE BENEFITS AGREEMENT (“Agreement”) is entered into as of the 1st day of January, 2024 by and between Sabra Health Care REIT, Inc. (“Employer” or “Sabra”) and Jessica Flores (“Employee”) with reference to the following facts: A. Employee will provide services to Employer as its Executive Vice President and Chief Accounting Officer; and B. In re
November 6, 2023	8-K	Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 6, 2023 SABRA HEALTH CARE REIT, INC. (Exact name of registrant as specified in its charter) Maryland 001-34950 27-2560479 (State of Incorporation) (Commission File Number) (I
November 6, 2023	EX-99.4	Cost Committed to Long-Term Value Investor Presentation \| November 6, 2023 November 6, 2023 Investor Presentation Forward-Looking Statements This presentation contains “forward-looking” statements as defined in the Private Securities Litigation Refor Cost Committed to Long-Term Value Investor Presentation \| November 6, 2023 November 6, 2023 Investor Presentation Forward-Looking Statements This presentation contains “forward-looking” statements as defined in the Private Securities Litigation Reform Act of 1995.
November 6, 2023	EX-99.1	SABRA HEALTH CARE REIT, INC. CONSOLIDATED STATEMENTS OF (LOSS) INCOME (dollars in thousands, except per share data) Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Revenues: Rental and related revenues (1) $ 93,08 Exhibit 99.1 FOR IMMEDIATE RELEASE SABRA REPORTS THIRD QUARTER 2023 RESULTS IRVINE, CA, November 6, 2023 — Sabra Health Care REIT, Inc. (“Sabra,” the “Company” or “we”) (Nasdaq: SBRA) today announced its results of operations for the third quarter of 2023. THIRD QUARTER 2023 RESULTS AND RECENT EVENTS •Results per diluted common share for the third quarter of 2023 were as follows: •Net Loss: $(0.07
November 6, 2023	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file numbe
November 6, 2023	EX-99.3	Reconciliations of Non-GAAP Financial Measures September 30, 2023 SABRA HEALTH CARE REIT, INC. RECONCILIATIONS OF NON-GAAP FINANCIAL MEASURES FFO, Normalized FFO, AFFO and Normalized AFFO (dollars in thousands, except per share data) Three Months End Reconciliations of Non-GAAP Financial Measures September 30, 2023 (Unaudited) SABRA HEALTH CARE REIT, INC.
November 6, 2023	EX-99.2	Exhibit 99.2 2 SABRA 3Q 2023 SUPPLEMENTAL INFORMATION September 30, 2023 03 COMPANY INFORMATION 04 OVERVIEW 05 PORTFOLIO Triple-Net Portfolio Top 10 Relationships Senior Housing - Managed Portfolio Loans and Other Investments NOI Concentrations Geogr Exhibit 99.2 2 SABRA 3Q 2023 SUPPLEMENTAL INFORMATION September 30, 2023 03 COMPANY INFORMATION 04 OVERVIEW 05 PORTFOLIO Triple-Net Portfolio Top 10 Relationships Senior Housing - Managed Portfolio Loans and Other Investments NOI Concentrations Geographic Concentrations - Consolidated Portfolio Triple-Net Lease Expirations 13 INVESTMENTS Summary Illustrative Annualized Cash NOI Upside 15 CAPITALIZ
August 7, 2023	EX-99.2	Exhibit 99.2 2 SABRA 2Q 2023 SUPPLEMENTAL INFORMATION June 30, 2023 03 COMPANY INFORMATION 04 OVERVIEW 05 PORTFOLIO Triple-Net Portfolio Top 10 Relationships Senior Housing - Managed Portfolio Loans and Other Investments NOI Concentrations Geographic sbraex9922023q2 Exhibit 99.2 2 SABRA 2Q 2023 SUPPLEMENTAL INFORMATION June 30, 2023 03 COMPANY INFORMATION 04 OVERVIEW 05 PORTFOLIO Triple-Net Portfolio Top 10 Relationships Senior Housing - Managed Portfolio Loans and Other Investments NOI Concentrations Geographic Concentrations - Consolidated Portfolio Triple-Net Lease Expirations 13 INVESTMENTS Summary Illustrative Annualized Cash NOI Upside 1
August 7, 2023	EX-99.1	SABRA HEALTH CARE REIT, INC. CONSOLIDATED STATEMENTS OF INCOME (dollars in thousands, except per share data) Three Months Ended June 30, Six Months Ended June 30, 2023 2022 2023 2022 Revenues: Rental and related revenues (1) $ 94,274 $ 103,168 $ 190, Exhibit 99.1 FOR IMMEDIATE RELEASE SABRA REPORTS SECOND QUARTER 2023 RESULTS IRVINE, CA, August 7, 2023 — Sabra Health Care REIT, Inc. (“Sabra,” the “Company” or “we”) (Nasdaq: SBRA) today announced its results of operations for the second quarter of 2023. SECOND QUARTER 2023 RESULTS AND RECENT EVENTS •Results per diluted common share for the second quarter of 2023 were as follows: •Net Income: $0
August 7, 2023	EX-99.4	Cost What Happens Inside Our Buildings Matters Most Investor Presentation \| August 7, 2023 Committed to Long-Term Value August 7, 2023 Investor Presentation Forward-Looking Statements This presentation contains “forward-looking” statements as defined sbraex9942023q2 Cost What Happens Inside Our Buildings Matters Most Investor Presentation \| August 7, 2023 Committed to Long-Term Value August 7, 2023 Investor Presentation Forward-Looking Statements This presentation contains “forward-looking” statements as defined in the Private Securities Litigation Reform Act of 1995.
August 7, 2023	EX-99.3	Reconciliations of Non-GAAP Financial Measures June 30, 2023 SABRA HEALTH CARE REIT, INC. RECONCILIATIONS OF NON-GAAP FINANCIAL MEASURES FFO, Normalized FFO, AFFO and Normalized AFFO (dollars in thousands, except per share data) Three Months Ended Ju Reconciliations of Non-GAAP Financial Measures June 30, 2023 (Unaudited) SABRA HEALTH CARE REIT, INC.
August 7, 2023	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001
August 7, 2023	8-K	Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 7, 2023 SABRA HEALTH CARE REIT, INC. (Exact name of registrant as specified in its charter) Maryland 001-34950 27-2560479 (State of Incorporation) (Commission File Number) (I.R
June 14, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 14, 2023 SABRA HEALTH CARE R UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 14, 2023 SABRA HEALTH CARE REIT, INC. (Exact name of registrant as specified in its charter) Maryland 001-34950 27-2560479 (State of Incorporation) (Commission File Number) (I.R.
May 3, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 3, 2023 SABRA HEALTH CARE REI UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 3, 2023 SABRA HEALTH CARE REIT, INC. (Exact name of registrant as specified in its charter) Maryland 001-34950 27-2560479 (State of Incorporation) (Commission File Number) (I.R.S.
May 3, 2023	EX-99.1	SABRA HEALTH CARE REIT, INC. CONSOLIDATED STATEMENTS OF (LOSS) INCOME (dollars in thousands, except per share data) Three Months Ended March 31, 2023 2022 Revenues: Rental and related revenues (1) $ 95,870 $ 109,886 Resident fees and services 56,721 Exhibit 99.1 FOR IMMEDIATE RELEASE SABRA REPORTS FIRST QUARTER 2023 RESULTS IRVINE, CA, May 3, 2023 — Sabra Health Care REIT, Inc. (“Sabra,” the “Company” or “we”) (Nasdaq: SBRA) today announced its results of operations for the first quarter of 2023. FIRST QUARTER 2023 RESULTS AND RECENT EVENTS •Results per diluted common share for the first quarter of 2023 were as follows: •Net Loss: $(0.04) •FF
May 3, 2023	EX-99.3	Reconciliations of Non-GAAP Financial Measures March 31, 2023 SABRA HEALTH CARE REIT, INC. RECONCILIATIONS OF NON-GAAP FINANCIAL MEASURES FFO, Normalized FFO, AFFO and Normalized AFFO (dollars in thousands, except per share data) Three Months Ended M Reconciliations of Non-GAAP Financial Measures March 31, 2023 (Unaudited) SABRA HEALTH CARE REIT, INC.
May 3, 2023	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 00
May 3, 2023	EX-99.4	Cost What Happens Inside Our Buildings Matters Most Investor Presentation \| May 2, 2023 Committed to Long-Term Value 3 May 3, 2023 Investor Presentation Forward-Looking Statements This presentation contains “forward-looking” statements as defined in sbraex9942023q1 Cost What Happens Inside Our Buildings Matters Most Investor Presentation \| May 2, 2023 Committed to Long-Term Value 3 May 3, 2023 Investor Presentation Forward-Looking Statements This presentation contains “forward-looking” statements as defined in the Private Securities Litigation Reform Act of 1995.
May 3, 2023	EX-99.2	Exhibit 99.2 2 SABRA 1Q 2023 SUPPLEMENTAL INFORMATION March 31, 2023 03 COMPANY INFORMATION 04 OVERVIEW 05 PORTFOLIO Triple-Net Portfolio Top 10 Relationships Senior Housing - Managed Portfolio Loans and Other Investments NOI Concentrations Geographi sbraex9922023q1 Exhibit 99.2 2 SABRA 1Q 2023 SUPPLEMENTAL INFORMATION March 31, 2023 03 COMPANY INFORMATION 04 OVERVIEW 05 PORTFOLIO Triple-Net Portfolio Top 10 Relationships Senior Housing - Managed Portfolio Loans and Other Investments NOI Concentrations Geographic Concentrations - Consolidated Portfolio Triple-Net Lease Expirations 13 INVESTMENT ACTIVITY Summary 14 CAPITALIZATION Overview Indeb
April 24, 2023	DEF 14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14
April 24, 2023	DEFA14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) DEFA14A 1 d404659ddefa14a.htm DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as
March 20, 2023	EX-99.1	Financial Statements of the Enlivant Joint Venture as of December 31, 2021 and 2022 (audited) and for the years ended December 31, 2020 (unaudited) and December 31, 2021 and 2022 (audited). ex9912022chief1financia CHIEF1 HOLDINGS, LLC AND SUBSIDIARIES (A Delaware Limited Liability Company) Consolidated Financial Statements December 31, 2022 and 2021, and Years ended December 31, 2022, 2021, and 2020 (With Independent Auditors’ Report Thereon) CHIEF1 HOLDINGS, LLC AND SUBSIDIARIES (A Delaware Limited Liability Company) Table of Contents Page Independent Auditors’ Report 1 Consolidated Statements of Financial Position 3 Consolidated Statements of Operations 4 Consolidated Statements of Members’ Deficit 5 Consolidated Statements of Cash Flows 6 Notes to Consolidated Financial Statements 7 Phone: 610.
March 20, 2023	10-K/A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1) (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number 001-34950 SABRA HEALTH CARE REIT, INC.
February 23, 2023	EX-FILING FEES	Calculation of Filing Fee Tables (Form Type) Sabra Health Care REIT, Inc. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered and Carry Forward Securities EX-FILING FEES Exhibit 107 Calculation of Filing Fee Tables 424(b)(5) (Form Type) Sabra Health Care REIT, Inc.
February 23, 2023	EX-1.1	Equity Distribution Agreement, dated February 23, 2023, among the Company, the Sales Agents party thereto, and the Forward Purchasers party thereto (incorporated by reference to Exhibit 1.1 of the Current Report on Form 8-K filed by Sabra Health Care REIT, Inc. on February 23, 2023). EX-1.1 Exhibit 1.1 SABRA HEALTH CARE REIT, INC. $500,000,000 of Shares of Common Stock (par value $0.01 per share) Equity Distribution Agreement February 23, 2023 Barclays Capital Inc. 745 Seventh Avenue New York, New York 10019 BMO Capital Markets Corp. 151 W 42nd Street New York, New York 10036 BofA Securities, Inc. One Bryant Park New York, New York 10036 Citigroup Global Markets Inc. 388 Green
February 23, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 23, 2023 SABRA HEALTH CA UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 23, 2023 SABRA HEALTH CARE REIT, INC. (Exact Name of Registrant as Specified in Its Charter) Maryland 001-34950 27-2560479 (State of Incorporation) (Commission File Number) (
February 23, 2023	424B5	$500,000,000 Sabra Health Care REIT, Inc. Common Stock 424B5 Table of Contents Filed Pursuant to Rule 424(b)(5) Registration No. 333-268285 PROSPECTUS SUPPLEMENT (To Prospectus Dated November 10, 2022) $500,000,000 Sabra Health Care REIT, Inc. Common Stock This prospectus supplement relates to our issuance and sale of shares of our common stock, par value $0.01 per share, having an aggregate offering price of up to $500,000,000 from time to time throu
February 21, 2023	EX-99.1	SABRA HEALTH CARE REIT, INC. CONSOLIDATED STATEMENTS OF LOSS (dollars in thousands, except per share data) Three Months Ended December 31, Year Ended December 31, 2022 2021 2022 2021 Revenues: Rental and related revenues (1) $ 103,318 $ 87,183 $ 400, Exhibit 99.1 FOR IMMEDIATE RELEASE SABRA REPORTS FOURTH QUARTER 2022 RESULTS IRVINE, CA, February 21, 2023 — Sabra Health Care REIT, Inc. (“Sabra,” the “Company” or “we”) (Nasdaq: SBRA) today announced its results of operations for the fourth quarter of 2022. FOURTH QUARTER 2022 RESULTS AND RECENT EVENTS •Results per diluted common share for the fourth quarter of 2022 were as follows: •Net Loss: $
February 21, 2023	10-K	Form 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number 001-34950 SABRA HEALTH CARE REIT, INC. (Exact Name of Regis
February 21, 2023	EX-21.1	List of Subsidiaries of Sabra Health Care REIT, Inc. Exhibit 21.1 Sabra Subsidiaries Entity Name Jurisdiction of Organization 1717 Senior Partners, LLC Indiana 2100 Benvoulin Court Holdings, Inc. British Columbia 2829-34th Street Holdings, Inc. British Columbia 317 Winnipeg St. Holdings Inc. British Columbia 3211 Alexis Park Drive Holdings Inc. British Columbia 870 Westminster Ave. Holdings, Inc. British Columbia Arden Real Estate Holdings, LLC Dela
February 21, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 21, 2023 SABRA HEALTH CA UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 21, 2023 SABRA HEALTH CARE REIT, INC. (Exact name of registrant as specified in its charter) Maryland 001-34950 27-2560479 (State of Incorporation) (Commission File Number) (
February 21, 2023	EX-99.4	Cost What Happens Inside Our Buildings Matters Most Investor Presentation \| February 21, 2023 February 21, 2023 Investor Presentation Forward-Looking Statements This presentation contains “forward-looking” statements as defined in the Private Securit sbraex9942022q4 Cost What Happens Inside Our Buildings Matters Most Investor Presentation \| February 21, 2023 February 21, 2023 Investor Presentation Forward-Looking Statements This presentation contains “forward-looking” statements as defined in the Private Securities Litigation Reform Act of 1995.
February 21, 2023	EX-99.3	Reconciliations of Non-GAAP Financial Measures December 31, 2022 SABRA HEALTH CARE REIT, INC. RECONCILIATIONS OF NON-GAAP FINANCIAL MEASURES FFO, Normalized FFO, AFFO and Normalized AFFO (dollars in thousands, except per share data) Three Months Ende Reconciliations of Non-GAAP Financial Measures December 31, 2022 (Unaudited) SABRA HEALTH CARE REIT, INC.
February 21, 2023	EX-99.2	Exhibit 99.2 2 SABRA 4Q 2022 SUPPLEMENTAL INFORMATION December 31, 2022 03 COMPANY INFORMATION 04 OVERVIEW 05 PORTFOLIO Triple-Net Portfolio Same Store Triple-Net Portfolio Top 10 Relationships Senior Housing - Managed Consolidated Portfolio Senior H sbraex9922022q4 Exhibit 99.2 2 SABRA 4Q 2022 SUPPLEMENTAL INFORMATION December 31, 2022 03 COMPANY INFORMATION 04 OVERVIEW 05 PORTFOLIO Triple-Net Portfolio Same Store Triple-Net Portfolio Top 10 Relationships Senior Housing - Managed Consolidated Portfolio Senior Housing - Managed Unconsolidated Portfolio Loans and Other Investments NOI Concentrations Geographic Concentrations - Consolidated Port
February 21, 2023	EX-4.1	Description of Sabra Health Care REIT, Inc.’s Capital Stock. EXHIBIT 4.1 DESCRIPTION OF CAPITAL STOCK OF SABRA HEALTH CARE REIT, INC. The following is a summary of the material terms of our capital stock as set forth in our Articles of Amendment and Restatement (our “charter) and our Amended and Restated Bylaws (our “bylaws”), which govern the rights of holders of our capital stock. The following summary does not purport to be complete and is subject to and
February 9, 2023	SC 13G/A	SBRA / Sabra Healthcare REIT, Inc. / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 13)* Name of issuer: Sabra Health Care REIT Inc. Title of Class of Securities: REIT CUSIP Number: 78573L106 Date of Event Which Requires Filing of this Statement: December 30, 2022 Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
January 5, 2023	EX-10.1	Sixth Amended and Restated Credit Agreement, dated January 4, 2023, among Sabra Health Care Limited Partnership and Sabra Canadian Holdings, LLC, as Borrowers; Sabra Health Care REIT, Inc., as a guarantor; the other guarantors party thereto; the lenders party thereto; Bank of America, N.A., as Administrative Agent and L/C Issuer; Citizens Bank, National Association, Crédit Agricole Corporate and Investment Bank and Wells Fargo Bank, National Association, as Co-Syndication Agents and L/C Issuers; The Bank of Nova Scotia, Fifth Third Bank, JPMorgan Chase Bank, N.A., Keybank National Association, Mizuho Bank, Ltd., and Truist Bank, as Co-Documentation Agents; BofA Securities, Inc., as Joint Lead Arranger and Sole Bookrunner; and Citizens Bank, National Association, Crédit Agricole Corporate and Investment Bank and Wells Fargo Securities, LLC, as Joint Lead Arrangers (incorporated by reference to Exhibit 10.1 of the Current Report on Form 8-K filed by Sabra Health Care REIT, Inc. on January 5, 2023). EX-10.1 2 d425254dex101.htm EX-10.1 Exhibit 10.1 Execution Copy Published Deal CUSIP Number: 78571QAZ0 Published USD Revolver Facility CUSIP Number: 78571QBA4 Published FX Revolver Facility CUSIP Number: 78571QBB2 Published USD Term Loan CUSIP Number: 78571QBC0 Published CAD Term Loan CUSIP Number: 78571QBD8 SIXTH AMENDED AND RESTATED CREDIT AGREEMENT Dated as of January 4, 2023 among SABRA HEALTH
January 5, 2023	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 4, 2023 SABRA HEALTH CARE REIT, INC. (Exact name of registrant as specified in its charter) Maryland 001-34950 27-2560479 (State of Incorporation) (Commission File Number) (I.
January 5, 2023	EX-99.1	Sabra Renews and Extends its Credit Facility Exhibit 99.1 Sabra Renews and Extends its Credit Facility 01/05/2023 IRVINE, Calif.?(BUSINESS WIRE)? Sabra Health Care REIT, Inc. (?Sabra?) (Nasdaq: SBRA) announced today that it has amended and restated its credit facility, improving its debt maturity profile while keeping capacity and pricing consistent with its prior credit facility. Summary: ? $1.0 billion unsecured revolving credit facility m
December 16, 2022	EX-3.1	Articles Supplementary of Sabra Health Care REIT, Inc., dated as of December 15, 2022 (incorporated by reference to Exhibit 3.1 of the Current Report on Form 8-K filed by Sabra Health Care REIT, Inc. on December 16, 2022). Exhibit 3.1 SABRA HEALTH CARE REIT, INC. ARTICLES SUPPLEMENTARY Sabra Health Care REIT, Inc., a Maryland corporation (the ?Company?), hereby certifies to the State Department of Assessments and Taxation of Maryland, that: FIRST: Under a power contained in Section 3-802(c) of the Maryland General Corporation Law (the ?MGCL?), the Company, by resolution of its Board of Directors (the ?Board of Direc
December 16, 2022	8-K	Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 15, 2022 SABRA HEALTH CARE REIT, INC. (Exact name of registrant as specified in its charter) Maryland 001-34950 27-2560479 (State of Incorporation) (Commission File Number) (
December 16, 2022	EX-3.2	Amended and Restated Bylaws of Sabra Health Care REIT, Inc. (incorporated by reference to Exhibit 3.2 of the Current Report on Form 8-K filed by Sabra Health Care REIT, Inc. on December 16, 2022). Exhibit 3.2 SABRA HEALTH CARE REIT, INC. AMENDED AND RESTATED BYLAWS (As Adopted on December 15, 2022) ARTICLE I OFFICES Section 1. PRINCIPAL OFFICE. The principal office of the Corporation in the State of Maryland shall be located at such place as the Board of Directors may designate. Section 2. ADDITIONAL OFFICES. The Corporation may have additional offices, including a principal executive offic
November 10, 2022	S-3ASR	As filed with the Securities and Exchange Commission on November 10, 2022 Table of Contents As filed with the Securities and Exchange Commission on November 10, 2022 Registration No.
November 10, 2022	EX-25.1	Statement of Eligibility and Qualification of Trustee under the Indenture under the Trust Indenture Act of 1939, as amended (filed herewith). Exhibit 25.1 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM T-1 STATEMENT OF ELIGIBILITY UNDER THE TRUST INDENTURE ACT OF 1939 OF A CORPORATION DESIGNATED TO ACT AS TRUSTEE CHECK IF AN APPLICATION TO DETERMINE ELIGIBILITY OF A TRUSTEE PURSUANT TO SECTION 305(b) (2) WELLS FARGO BANK, NATIONAL ASSOCIATION (Exact name of trustee as specified in its charter) A National Banking Associat
November 10, 2022	EX-FILING FEES	Calculation of Filing Fee Table (filed herewith). Exhibit 107 Calculation of Filing Fee Tables Form S-3 (Form Type) Sabra Health Care REIT, Inc.
November 10, 2022	8-K	Termination of a Material Definitive Agreement UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 9, 2022 SABRA HEALTH CARE REIT, INC. (Exact name of registrant as specified in its charter) Maryland 001-34950 27-2560479 (State of Incorporation) (Commission File Number) (I
November 7, 2022	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file numbe
November 7, 2022	EX-99.4	Cost What Happens Inside Our Buildings Matters Most Investor Presentation \| November 7, 2022 November 7, 2022 Investor Presentation Forward-Looking Statements This presentation contains “forward-looking” statements as defined in the Private Securitie Cost What Happens Inside Our Buildings Matters Most Investor Presentation \| November 7, 2022 November 7, 2022 Investor Presentation Forward-Looking Statements This presentation contains ?forward-looking? statements as defined in the Private Securities Litigation Reform Act of 1995.
November 7, 2022	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 7, 2022 SABRA HEALTH CAR UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 7, 2022 SABRA HEALTH CARE REIT, INC. (Exact name of registrant as specified in its charter) Maryland 001-34950 27-2560479 (State of Incorporation) (Commission File Number) (I
November 7, 2022	EX-99.3	Reconciliations of Non-GAAP Financial Measures September 30, 2022 SABRA HEALTH CARE REIT, INC. RECONCILIATIONS OF NON-GAAP FINANCIAL MEASURES FFO, Normalized FFO, AFFO and Normalized AFFO (dollars in thousands, except per share data) Three Months End Reconciliations of Non-GAAP Financial Measures September 30, 2022 (Unaudited) SABRA HEALTH CARE REIT, INC.
November 7, 2022	EX-99.2	Exhibit 99.2 2 SABRA 3Q 2022 SUPPLEMENTAL INFORMATION September 30, 2022 03 COMPANY INFORMATION 04 OVERVIEW 05 PORTFOLIO Triple-Net Portfolio Same Store Triple-Net Portfolio Top 10 Relationships Senior Housing - Managed Consolidated Portfolio Senior Exhibit 99.2 2 SABRA 3Q 2022 SUPPLEMENTAL INFORMATION September 30, 2022 03 COMPANY INFORMATION 04 OVERVIEW 05 PORTFOLIO Triple-Net Portfolio Same Store Triple-Net Portfolio Top 10 Relationships Senior Housing - Managed Consolidated Portfolio Senior Housing - Managed Unconsolidated Portfolio Loans and Other Investments NOI Concentrations Geographic Concentrations - Consolidated Portfolio Triple-Ne
November 7, 2022	EX-99.1	SABRA HEALTH CARE REIT, INC. CONSOLIDATED STATEMENTS OF (LOSS) INCOME (dollars in thousands, except per share data) Three Months Ended September 30, Nine Months Ended September 30, 2022 2021 2022 2021 Revenues: Rental and related revenues (1) $ 84,21 Exhibit 99.1 FOR IMMEDIATE RELEASE SABRA REPORTS THIRD QUARTER 2022 RESULTS; PROVIDES BUSINESS UPDATE IRVINE, CA, November 7, 2022 ? Sabra Health Care REIT, Inc. (?Sabra,? the ?Company? or ?we?) (Nasdaq: SBRA) today announced its results of operations for the third quarter of 2022. In addition, the Company provided a business update. THIRD QUARTER 2022 RESULTS AND RECENT EVENTS ?Results per dilute
August 3, 2022	EX-99.1	SABRA HEALTH CARE REIT, INC. CONSOLIDATED STATEMENTS OF INCOME (LOSS) (dollars in thousands, except per share data) Three Months Ended June 30, Six Months Ended June 30, 2022 2021 2022 2021 Revenues: Rental and related revenues (1) $ 103,168 $ 110,78 Exhibit 99.1 FOR IMMEDIATE RELEASE SABRA REPORTS SECOND QUARTER 2022 RESULTS; PROVIDES BUSINESS UPDATE IRVINE, CA, August 3, 2022 ? Sabra Health Care REIT, Inc. (?Sabra,? the ?Company? or ?we?) (Nasdaq: SBRA) today announced its results of operations for the second quarter of 2022. In addition, the Company provided a business update. SECOND QUARTER 2022 RESULTS AND RECENT EVENTS ?Results per dilut
August 3, 2022	EX-99.2	Exhibit 99.2 2 SABRA 2Q 2022 SUPPLEMENTAL INFORMATION June 30, 2022 03 COMPANY INFORMATION 04 OVERVIEW 05 PORTFOLIO Triple-Net Portfolio Same Store Triple-Net Portfolio Top 10 Relationships Medicaid Trends Senior Housing - Managed Consolidated Portfo Exhibit 99.2 2 SABRA 2Q 2022 SUPPLEMENTAL INFORMATION June 30, 2022 03 COMPANY INFORMATION 04 OVERVIEW 05 PORTFOLIO Triple-Net Portfolio Same Store Triple-Net Portfolio Top 10 Relationships Medicaid Trends Senior Housing - Managed Consolidated Portfolio Senior Housing - Managed Unconsolidated Portfolio Loans and Other Investments \| Development Pipeline NOI Concentrations Geographic Concentrations
August 3, 2022	EX-99.4	Cost What Happens Inside Our Buildings Matters Most Investor Presentation \| May 4, 2022August 3, 2022 August 3, 2022 Investor Presentation Forward-Looking Statements This presentation contains “forward-looking” statements as defined in the Private Se Cost What Happens Inside Our Buildings Matters Most Investor Presentation \| May 4, 2022August 3, 2022 August 3, 2022 Investor Presentation Forward-Looking Statements This presentation contains ?forward-looking? statements as defined in the Private Securities Litigation Reform Act of 1995.
August 3, 2022	8-K	Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 3, 2022 SABRA HEALTH CARE REIT, INC. (Exact name of registrant as specified in its charter) Maryland 001-34950 27-2560479 (State of Incorporation) (Commission File Number) (I.R
August 3, 2022	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001
August 3, 2022	EX-99.3	Reconciliations of Non-GAAP Financial Measures June 30, 2022 SABRA HEALTH CARE REIT, INC. RECONCILIATIONS OF NON-GAAP FINANCIAL MEASURES FFO, Normalized FFO, AFFO and Normalized AFFO (dollars in thousands, except per share data) Three Months Ended Ju Reconciliations of Non-GAAP Financial Measures June 30, 2022 (Unaudited) SABRA HEALTH CARE REIT, INC.
June 14, 2022	8-K	Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 14, 2022 SABRA HEALTH CARE REIT, INC. (Exact name of registrant as specified in its charter) Maryland 001-34950 27-2560479 (State of Incorporation) (Commission File Number) (I.R.
May 19, 2022	CORRESP	* * * May 19, 2022 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance Office of Real Estate & Construction 100 F Street, N.
May 4, 2022	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 00
May 4, 2022	EX-99.3	Reconciliations of Non-GAAP Financial Measures March 31, 2022 SABRA HEALTH CARE REIT, INC. RECONCILIATIONS OF NON-GAAP FINANCIAL MEASURES FFO, Normalized FFO, AFFO and Normalized AFFO (dollars in thousands, except per share data) Three Months Ended M EX-99.3 4 sbraex9932022q1.htm Q1 2022 NON-GAAP RECONCILIATIONS Reconciliations of Non-GAAP Financial Measures March 31, 2022 (Unaudited) SABRA HEALTH CARE REIT, INC. RECONCILIATIONS OF NON-GAAP FINANCIAL MEASURES FFO, Normalized FFO, AFFO and Normalized AFFO (dollars in thousands, except per share data) Three Months Ended March 31, 2022 2021 Net income $ 40,602 $ 33,447 Add: Depreciation and amort
May 4, 2022	8-K	Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 4, 2022 SABRA HEALTH CARE REIT, INC. (Exact name of registrant as specified in its charter) Maryland 001-34950 27-2560479 (State of Incorporation) (Commission File Number) (I.R.S.
May 4, 2022	EX-99.1	SABRA HEALTH CARE REIT, INC. CONSOLIDATED STATEMENTS OF INCOME (dollars in thousands, except per share data) Three Months Ended March 31, 2022 2021 Revenues: Rental and related revenues (1) $ 109,886 $ 113,383 Interest and other income 10,992 2,941 R Exhibit 99.1 FOR IMMEDIATE RELEASE SABRA REPORTS FIRST QUARTER 2022 RESULTS; PROVIDES BUSINESS UPDATE IRVINE, CA, May 4, 2022 ? Sabra Health Care REIT, Inc. (?Sabra,? the ?Company? or ?we?) (Nasdaq: SBRA) today announced its results of operations for the first quarter of 2022. In addition, the Company provided a business update. FIRST QUARTER 2022 RESULTS AND RECENT EVENTS ?Results per diluted com
May 4, 2022	EX-99.2	Exhibit 99.2 2 SABRA 1Q 2022 SUPPLEMENTAL INFORMATION March 31, 2022 03 COMPANY INFORMATION 04 OVERVIEW 05 PORTFOLIO Triple-Net Portfolio Same Store Triple-Net Portfolio Top 10 Relationships Senior Housing - Managed Portfolio Loans and Other Investme Exhibit 99.2 2 SABRA 1Q 2022 SUPPLEMENTAL INFORMATION March 31, 2022 03 COMPANY INFORMATION 04 OVERVIEW 05 PORTFOLIO Triple-Net Portfolio Same Store Triple-Net Portfolio Top 10 Relationships Senior Housing - Managed Portfolio Loans and Other Investments \| Development Pipeline NOI Concentrations Geographic Concentrations Lease Expirations 14 INVESTMENT ACTIVITY Summary 15 CAPITALIZATION Overview In
May 4, 2022	EX-99.4	What Happens Inside Our Buildings Matters Most Investor Presentation \| May 4, 2022 Forward-Looking Statements This presentation contains “forward-looking” statements as defined in the Private Securities Litigation Reform Act of 1995. Any statements t What Happens Inside Our Buildings Matters Most Investor Presentation \| May 4, 2022 Forward-Looking Statements This presentation contains ?forward-looking? statements as defined in the Private Securities Litigation Reform Act of 1995.
April 25, 2022	DEFA14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Defin
April 25, 2022	DEF 14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14
March 30, 2022	10-K/A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1) (Mark One) ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number 001-34950 SABRA HEALTH CARE REIT, INC.
March 30, 2022	EX-99.1	Financial Statements of the Enlivant Joint Venture as of December 31, 2020 (unaudited) and December 31, 2021 (audited) and for the years ended December 31, 2019 and 2020 (unaudited) and December 31, 2021 (audited). CHIEF1 HOLDINGS, LLC AND SUBSIDIARIES (A Delaware Limited Liability Company) Consolidated Financial Statements December 31, 2021 and 2020, and Years ended December 31, 2021, 2020, and 2019 (With Independent Auditors? Report Thereon) CHIEF1 HOLDINGS, LLC AND SUBSIDIARIES (A Delaware Limited Liability Company) Table of Contents Page Independent Auditors? Report 1 Consolidated Statements of Financial Position 3 Consolidated Statements of Operations and Comprehensive Loss 4 Consolidated Statements of Members? Deficit 5 Consolidated Statements of Cash Flows 6 Notes to Consolidated Financial Statements 7 401 Plymouth Road, Suite 200 ? Plymouth Meeting, PA 19462 Main: 610.
February 22, 2022	EX-99.2	Exhibit 99.2 2 SABRA 4Q 2021 SUPPLEMENTAL INFORMATION December 31, 2021 03 COMPANY INFORMATION 04 OVERVIEW 05 PORTFOLIO Triple-Net Portfolio Same Store Triple-Net Portfolio Top 10 Relationships Senior Housing - Managed Portfolio Loans and Other Inves Exhibit 99.2 2 SABRA 4Q 2021 SUPPLEMENTAL INFORMATION December 31, 2021 03 COMPANY INFORMATION 04 OVERVIEW 05 PORTFOLIO Triple-Net Portfolio Same Store Triple-Net Portfolio Top 10 Relationships Senior Housing - Managed Portfolio Loans and Other Investments \| Development Pipeline NOI Concentrations Geographic Concentrations Lease Expirations 14 INVESTMENT ACTIVITY Summary Recent 17 CAPITALIZATION O
February 22, 2022	EX-99.4	What Happens Inside Our Buildings Matters Most Investor Presentation \| February 22, 2022 Forward-Looking Statements This presentation contains “forward-looking” statements, as defined in the Private Securities Litigation Reform Act of 1995, that may What Happens Inside Our Buildings Matters Most Investor Presentation \| February 22, 2022 Forward-Looking Statements This presentation contains ?forward-looking? statements, as defined in the Private Securities Litigation Reform Act of 1995, that may be identified, without limitation, by the use of ?expects,? ?believes,? ?intends,? ?should? or comparable terms or the negative thereof.
February 22, 2022	EX-22.1	List of Subsidiary Issuers and Guarantors of Sabra Health Care REIT, Inc. (incorporated by reference to Exhibit 22.1 of the Annual Report on 10-K filed by Sabra Health Care REIT, Inc. on February 22, 2022). EXHIBIT 22.1 List of Subsidiary Issuers and Guarantors of Sabra Health Care REIT, Inc. Sabra Health Care Limited Partnership (the ?Operating Partnership?), a Delaware limited partnership and subsidiary of Sabra Health Care REIT, Inc. (the ?Company?), is the issuer of the following securities registered under the Securities Act of 1933, as amended, for which the Company is the guarantor: (i) $500.0
February 22, 2022	EX-99.1	SABRA HEALTH CARE REIT, INC. CONDENSED CONSOLIDATED STATEMENTS OF (LOSS) INCOME (dollars in thousands, except per share data) Three Months Ended December 31, Year Ended December 31, 2021 2020 2021 2020 Revenues: Rental and related revenues (1) $ 87,1 Exhibit 99.1 FOR IMMEDIATE RELEASE SABRA REPORTS FOURTH QUARTER 2021 RESULTS; PROVIDES BUSINESS UPDATE IRVINE, CA, February 22, 2022 ? Sabra Health Care REIT, Inc. (?Sabra,? the ?Company? or ?we?) (Nasdaq: SBRA) today announced its results of operations for the fourth quarter of 2021. In addition, the Company provided a business update. FOURTH QUARTER 2021 RESULTS AND RECENT EVENTS ?Results per di
February 22, 2022	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number 001-34950 SABRA HEALTH CARE REIT, INC. (Exact Name of Regis
February 22, 2022	EX-4.1	Description of Sabra Health Care REIT, Inc.’s Capital Stock. EXHIBIT 4.1 DESCRIPTION OF CAPITAL STOCK OF SABRA HEALTH CARE REIT, INC. The following is a summary of the material terms of our capital stock as set forth in our Articles of Amendment and Restatement (our ?charter) and our Amended and Restated Bylaws (our ?bylaws?), which govern the rights of holders of our capital stock. The following summary does not purport to be complete and is subject to and
February 22, 2022	EX-99.3	Reconciliations of Non-GAAP Financial Measures December 31, 2021 SABRA HEALTH CARE REIT, INC. RECONCILIATIONS OF NON-GAAP FINANCIAL MEASURES FFO, Normalized FFO, AFFO and Normalized AFFO (dollars in thousands, except per share data) Three Months Ende Reconciliations of Non-GAAP Financial Measures December 31, 2021 (Unaudited) SABRA HEALTH CARE REIT, INC.
February 22, 2022	8-K	Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 22, 2022 SABRA HEALTH CARE REIT, INC. (Exact name of registrant as specified in its charter) Maryland 001-34950 27-2560479 (State of Incorporation) (Commission File Number) (
February 22, 2022	EX-21.1	List of Subsidiaries of Sabra Health Care REIT, Inc. Exhibit 21.1 Sabra Subsidiaries Entity Name Jurisdiction of Organization 1717 Senior Partners, LLC (Subsidiary of Joint Venture) Indiana 2100 Benvoulin Court Holdings, Inc. British Columbia 2829-34th Street Holdings, Inc. British Columbia 317 Winnipeg St. Holdings Inc. British Columbia 3211 Alexis Park Drive Holdings Inc. British Columbia 870 Westminster Ave. Holdings, Inc. British Columbia Arden
February 10, 2022	SC 13G/A	SBRA / Sabra Healthcare REIT, Inc. / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 12)* Name of issuer: Sabra Health Care REIT Inc. Title of Class of Securities: REIT CUSIP Number: 78573L106 Date of Event Which Requires Filing of this Statement: December 31, 2021 Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
February 8, 2022	EX-99.1	Sabra Announces Raymond J. Lewis Has Resigned from its Board of Directors Sabra Announces Raymond J. Lewis Has Resigned from its Board of Directors IRVINE, Calif., February 8, 2022 (BUSINESS WIRE) ? Sabra Health Care REIT, Inc. (?Sabra,? the ?Company? or ?we?) (Nasdaq: SBRA) announced that Raymond J. Lewis resigned from the Company?s Board of Directors on February 7, 2022. Rick Matros, CEO and Chairman of Sabra, said ?Ray has been a fantastic Board member and his contri
February 8, 2022	EX-3.1	Amended and Restated Bylaws of Sabra Health Care REIT, Inc. (incorporated by reference to Exhibit 3.1 of the Current Report on Form 8-K filed by Sabra Health Care REIT, Inc. on February 8, 2022). SABRA HEALTH CARE REIT, INC. AMENDED AND RESTATED BYLAWS (As Adopted on February 7, 2022) ARTICLE I OFFICES Section 1. PRINCIPAL OFFICE. The principal office of the Corporation in the State of Maryland shall be located at such place as the Board of Directors may designate. Section 2. ADDITIONAL OFFICES. The Corporation may have additional offices, including a principal executive office, at such pl
February 8, 2022	8-K	Regulation FD Disclosure, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 7, 2022 SABRA HEALTH CARE REIT, INC. (Exact name of registrant as specified in its charter) Maryland 001-34950 27-2560479 (State of Incorporation) (Commission File Number) (I
January 27, 2022	EX-99.1	What Happens Inside Our Buildings Matters Most Stifel 2022 Seniors Housing and Healthcare Real Estate Conference \| January 27, 2022 Forward-Looking Statements This presentation contains “forward-looking” statements, as defined in the Private Securiti EX-99.1 2 stifeljan2022.htm EX-99.1 What Happens Inside Our Buildings Matters Most Stifel 2022 Seniors Housing and Healthcare Real Estate Conference \| January 27, 2022 Forward-Looking Statements This presentation contains “forward-looking” statements, as defined in the Private Securities Litigation Reform Act of 1995, that may be identified, without limitation, by the use of “expects,” “believes,”
January 27, 2022	8-K	Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 27, 2022 SABRA HEALTH CARE REIT, INC. (Exact name of registrant as specified in its charter) Maryland 001-34950 27-2560479 (State of Incorporation) (Commission File Number) (I
January 25, 2022	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 24, 2022 SABRA HEALTH CARE REIT, INC. (Exact name of registrant as specified in its charter) Maryland 001-34950 27-2560479 (State of Incorporation) (Commission File Number) (I
January 10, 2022	8-K	Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 10, 2022 SABRA HEALTH CARE REIT, INC. (Exact name of registrant as specified in its charter) Maryland 001-34950 27-2560479 (State of Incorporation) (Commission File Number) (I
January 10, 2022	EX-99.1	What Happens Inside Our Buildings Matters Most Capital One Securities 2nd Annual REIT Conference \| January 10-11, 2022 Forward-Looking Statements This presentation contains “forward-looking” statements, as defined in the Private Securities Litigation What Happens Inside Our Buildings Matters Most Capital One Securities 2nd Annual REIT Conference \| January 10-11, 2022 Forward-Looking Statements This presentation contains ?forward-looking? statements, as defined in the Private Securities Litigation Reform Act of 1995, that may be identified, without limitation, by the use of ?expects,? ?believes,? ?intends,? ?should? or comparable terms or the negative thereof.
January 3, 2022	EX-10.3	Form of Indemnification Agreement entered into with each of the directors and officers of Sabra Health Care REIT, Inc. (incorporated by reference to Exhibit 10.3 of the Current Report on Form 8-K filed by Sabra Health Care REIT, Inc. on January 3, 2022). Exhibit 10.3 INDEMNIFICATION AGREEMENT THIS INDEMNIFICATION AGREEMENT (?Agreement?) is made and entered into as of the day of , 20, by and between Sabra Health Care REIT, Inc., a Maryland corporation (the ?Company?), and (?Indemnitee?). WHEREAS, at the request of the Company, Indemnitee currently serves as [a director] [and] [an officer] of the Company and may, therefore, be subjected to claims, s
January 3, 2022	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 30, 2021 SABRA HEALTH CARE REIT, INC. (Exact Name of Registrant as Specified in Its Charter) Maryland 001-34950 27-2560479 (State of Incorporation) (Commission File Number) (
January 3, 2022	EX-10.1	Employment Agreement, dated January 1, 2022, by and between Michael Costa and Sabra Health Care REIT, Inc. (incorporated by reference to Exhibit 10.1 of the Current Report on Form 8-K filed by Sabra Health Care REIT, Inc. on January 3, 2022). Exhibit 10.1 EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT (?Agreement?) is entered into this 1st day of January, 2022 (the ?Effective Date?), by and between Michael L. Costa (?Executive?) and Sabra Health Care REIT, Inc., a Maryland corporation (?Sabra? or the ?Company?). WHEREAS, Executive has been appointed as Executive Vice President, Chief Financial Officer (?CFO?) and Secretary of Sabra as
January 3, 2022	EX-10.2	Consulting Agreement, dated December 30, 2021, by and between Harold W. Andrews, Jr. and Sabra Health Care REIT, Inc. (incorporated by reference to Exhibit 10.2 of the Current Report on Form 8-K filed by Sabra Health Care REIT, Inc. on January 3, 2022). Exhibit 10.2 CONSULTING AGREEMENT This Consulting Agreement (?Agreement?), dated as of December 30, 2021 and effective as of December 31, 2021 (the ?Effective Date?), is made and entered into by and between Harold W. Andrews, Jr. (?Consultant?) and Sabra Health Care REIT, Inc. (?Company?). WHEREAS, Consultant will be retiring from his position as Chief Financial Officer of the Company effective De
December 15, 2021	8-K	Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 15, 2021 SABRA HEALTH CARE REIT, INC. (Exact name of registrant as specified in its charter) Maryland 001-34950 27-2560479 (State of Incorporation) (Commission File Number) (
December 15, 2021	EX-99.1	What Happens Inside Our Buildings Matters Most Jefferies Real Estate Conference \| December 15-16, 2021 Forward-Looking Statements This presentation contains “forward-looking” statements, as defined in the Private Securities Litigation Reform Act of 1 What Happens Inside Our Buildings Matters Most Jefferies Real Estate Conference \| December 15-16, 2021 Forward-Looking Statements This presentation contains ?forward-looking? statements, as defined in the Private Securities Litigation Reform Act of 1995, that may be identified, without limitation, by the use of ?expects,? ?believes,? ?intends,? ?should? or comparable terms or the negative thereof.
November 9, 2021	EX-99.1	What Happens Inside Our Buildings Matters Most Nareit’s REITworld 2021 Annual Conference \| November 9-11, 2021 Forward-Looking Statements This presentation contains “forward-looking” statements, as defined in the Private Securities Litigation Reform What Happens Inside Our Buildings Matters Most Nareit?s REITworld 2021 Annual Conference \| November 9-11, 2021 Forward-Looking Statements This presentation contains ?forward-looking? statements, as defined in the Private Securities Litigation Reform Act of 1995, that may be identified, without limitation, by the use of ?expects,? ?believes,? ?intends,? ?should? or comparable terms or the negative thereof.
November 9, 2021	8-K	Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 9, 2021 SABRA HEALTH CARE REIT, INC. (Exact name of registrant as specified in its charter) Maryland 001-34950 27-2560479 (State of Incorporation) (Commission File Number) (I
November 3, 2021	EX-99.3	Reconciliations of Non-GAAP Financial Measures September 30, 2021 SABRA HEALTH CARE REIT, INC. RECONCILIATIONS OF NON-GAAP FINANCIAL MEASURES FFO, Normalized FFO, AFFO and Normalized AFFO (dollars in thousands, except per share data) Three Months End Reconciliations of Non-GAAP Financial Measures September 30, 2021 (Unaudited) SABRA HEALTH CARE REIT, INC.
November 3, 2021	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file numbe
November 3, 2021	EX-99.2	Exhibit 99.2 2 SABRA 3Q 2021 SUPPLEMENTAL INFORMATION September 30, 2021 03 COMPANY INFORMATION 04 OVERVIEW 05 PORTFOLIO Triple-Net Portfolio Same Store Triple-Net Portfolio Top 10 Relationships and COVID-19 Mitigation Summary Senior Housing - Manage Exhibit 99.2 2 SABRA 3Q 2021 SUPPLEMENTAL INFORMATION September 30, 2021 03 COMPANY INFORMATION 04 OVERVIEW 05 PORTFOLIO Triple-Net Portfolio Same Store Triple-Net Portfolio Top 10 Relationships and COVID-19 Mitigation Summary Senior Housing - Managed Portfolio Loans and Other Investments \| Development Pipeline NOI Concentrations Geographic Concentrations Lease Expirations 14 INVESTMENT ACTIVITY S
November 3, 2021	EX-99.1	SABRA HEALTH CARE REIT, INC. CONDENSED CONSOLIDATED STATEMENTS OF INCOME (LOSS) (dollars in thousands, except per share data) Three Months Ended September 30, Nine Months Ended September 30, 2021 2020 2021 2020 Revenues: Rental and related revenues ( Exhibit 99.1 FOR IMMEDIATE RELEASE SABRA REPORTS THIRD QUARTER 2021 RESULTS; PROVIDES BUSINESS UPDATE; REAFFIRMS 2021 NFFO AND NAFFO GUIDANCE IRVINE, CA, November 3, 2021 ? Sabra Health Care REIT, Inc. (?Sabra,? the ?Company? or ?we?) (Nasdaq: SBRA) today announced its results of operations for the third quarter of 2021. In addition, the Company provided a business update, reaffirmed its full-year
November 3, 2021	EX-22.1	List of Subsidiary Issuers and Guarantors of Sabra Health Care REIT, Inc. EXHIBIT 22.1 List of Subsidiary Issuers and Guarantors of Sabra Health Care REIT, Inc. Outstanding Senior Unsecured Notes: Sabra Health Care Limited Partnership (the ?Operating Partnership?), a Delaware limited partnership and subsidiary of Sabra Health Care REIT, Inc. (the ?Company?), is the issuer of the following securities registered under the Securities Act of 1933, as amended, for which the
November 3, 2021	8-K	Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 3, 2021 SABRA HEALTH CARE REIT, INC. (Exact name of registrant as specified in its charter) Maryland 001-34950 27-2560479 (State of Incorporation) (Commission File Number) (I
October 18, 2021	EX-99.1	Sabra Health Care REIT, Inc. Closes on Previously Announced RCA Mortgage Loan and an Additional Investment; Transitions Three Skilled Nursing Facilities to affiliates of The Ensign Group Exhibit 99.1 Sabra Health Care REIT, Inc. Closes on Previously Announced RCA Mortgage Loan and an Additional Investment; Transitions Three Skilled Nursing Facilities to affiliates of The Ensign Group IRVINE, CA (BUSINESSWIRE) Sabra Health Care REIT, Inc. (?Sabra,? the ?Company? or ?we?) (Nasdaq: SBRA) today announced the closing of two investments and the transition of three facilities to affiliat
October 18, 2021	8-K	Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 18, 2021 SABRA HEALTH CARE REIT, INC. (Exact Name of Registrant as Specified in Its Charter) Maryland 001-34950 27-2560479 (State of Incorporation) (Commission File Number) (I
October 15, 2021	EX-1.1	Underwriting Agreement, dated October 12, 2021, by and among the Company and Citigroup Global Markets Inc., Barclays Capital Inc. and Wells Fargo Securities, LLC. Exhibit 1.1 [Execution Version] 6,800,000 Firm Shares Sabra Health Care REIT, Inc. UNDERWRITING AGREEMENT October 12, 2021 Citigroup Global Markets Inc. 388 Greenwich Street New York, New York 10013 Barclays Capital Inc. 745 Seventh Avenue New York, New York 10019 Wells Fargo Securities, LLC 500 West 33rd Street, 14th Floor New York, New York 10001 Ladies and Gentlemen: Sabra Health Care REIT, Inc
October 15, 2021	8-K	Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 12, 2021 SABRA HEALTH CARE REIT, INC. (Exact Name of Registrant as Specified in Its Charter) Maryland 001-34950 27-2560479 (State of Incorporation) (Commission File Number) (I
October 14, 2021	424B5	CALCULATION OF REGISTRATION FEE Title of Each Class of Securities to be Registered Amount to be Registered Maximum Offering Price per Unit Maximum Aggregate Offering Price Amount of Registration Fee Common stock, par value $0.01 per share 7,820,000 ( Table of Contents Filed Pursuant to Rule 424(b)(5) Registration No. 333-235449 CALCULATION OF REGISTRATION FEE Title of Each Class of Securities to be Registered Amount to be Registered Maximum Offering Price per Unit Maximum Aggregate Offering Price Amount of Registration Fee Common stock, par value $0.01 per share 7,820,000 (1) $14.70 (2) $114,954,000 (2) $10,656.24 (1) Assumes exercise in full
October 12, 2021	424B5	The information in this preliminary prospectus supplement is not complete and may be changed. SUBJECT TO COMPLETION, DATED OCTOBER 12, 2021 Table of Contents Filed Pursuant to Rule 424(b)(5) Registration No. 333-235449 The information in this preliminary prospectus supplement is not complete and may be changed. SUBJECT TO COMPLETION, DATED OCTOBER 12, 2021 PROSPECTUS SUPPLEMENT (To Prospectus Dated December 11, 2019) 6,800,000 Shares Sabra Health Care REIT, Inc. Common Stock We are offering 6,800,000 shares of our common stock. Our co
September 30, 2021	EX-4.1	Indenture, dated as of September 30, 2021, among Sabra Health Care Limited Partnership, Sabra Health Care REIT, Inc., and Wells Fargo Bank, National Association, as Trustee (incorporated by reference to Exhibit 4.1 of the Current Report on Form 8-K filed by Sabra Health Care REIT, Inc. on September 30, 2021). EX-4.1 3 d226114dex41.htm EX-4.1 Exhibit 4.1 EXECUTION VERSION SABRA HEALTH CARE LIMITED PARTNERSHIP, as Issuer, SABRA HEALTH CARE REIT, INC., as Parent and Guarantor, AND WELLS FARGO BANK, NATIONAL ASSOCIATION, as TRUSTEE INDENTURE Dated as of September 30, 2021 Debt Securities ARTICLE 1 DEFINITIONS AND OTHER PROVISIONS OF GENERAL APPLICATION 1 Section 1.1 Definitions 1 Section 1.2 Other Definiti
September 30, 2021	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): September 30, 2021 SABRA HEALTH CARE REIT, INC. (Exact Name of Registrant as Specified in Its Charter) Maryland 001-34950 27-2560479 (State of Incorporation) (Commission File Number)
September 30, 2021	EX-4.2	First Supplemental Indenture, dated September 30, 2021, among Sabra Health Care Limited Partnership, Sabra Health Care REIT, Inc. and Wells Fargo Bank, National Association, as Trustee (incorporated by reference to Exhibit 4.2 of the Current Report on Form 8-K filed by Sabra Health Care REIT, Inc. on September 30, 2021). Exhibit 4.2 EXECUTION VERSION SABRA HEALTH CARE LIMITED PARTNERSHIP as Issuer, SABRA HEALTH CARE REIT, INC., as Parent and Guarantor, and WELLS FARGO BANK, NATIONAL ASSOCIATION, as Trustee FIRST SUPPLEMENTAL INDENTURE Dated as of September 30, 2021 To the Indenture dated as of September 30, 2021 Establishing a series of Securities designated 3.200% Senior Notes due 2031 CROSS-REFERENCE TABLE Trust
September 30, 2021	EX-1.1	Amendment No. 1 to the Underwriting Agreement, dated September 30, 2021, by and among Sabra Health Care REIT, Inc., Sabra Health Care Limited Partnership, and Wells Fargo Securities, LLC, BofA Securities, Inc., Credit Agricole Securities (USA) Inc. and J.P. Morgan Securities LLC, as representatives of the several underwriters named therein. Exhibit 1.1 EXECUTION VERSION Sabra Health Care REIT, Inc. Sabra Health Care Limited Partnership $800,000,000 3.200% Senior Notes due 2031 AMENDMENT NO. 1 TO THE UNDERWRITING AGREEMENT September 30, 2021 Wells Fargo Securities, LLC BofA Securities, Inc. Credit Agricole Securities (USA) Inc. J.P. Morgan Securities LLC As Representatives of the several Underwriters named in Schedule A to the Underwr
September 24, 2021	8-K	Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): September 22, 2021 SABRA HEALTH CARE REIT, INC. (Exact name of registrant as specified in its charter) Maryland 001-34950 27-2560479 (State of Incorporation) (Commission File Number)
September 24, 2021	EX-3.1	Amended and Restated Bylaws of Sabra Health Care REIT, Inc. SABRA HEALTH CARE REIT, INC. AMENDED AND RESTATED BYLAWS (As Adopted on September 22, 2021) ARTICLE I OFFICES Section 1. PRINCIPAL OFFICE. The principal office of the Corporation in the State of Maryland shall be located at such place as the Board of Directors may designate. Section 2. ADDITIONAL OFFICES. The Corporation may have additional offices, including a principal executive office, at such
September 22, 2021	424B5	CALCULATION OF REGISTRATION FEE Title of Each Class of Securities to be Registered Amount to be Registered Maximum Offering Price per Unit Maximum Aggregate Offering Price Amount of Registration Fee 3.200% Senior Notes due 2031 $800,000,000 98.940% $ Table of Contents Filed Pursuant to Rule 424(b)(5) Registration No. 333-235449 CALCULATION OF REGISTRATION FEE Title of Each Class of Securities to be Registered Amount to be Registered Maximum Offering Price per Unit Maximum Aggregate Offering Price Amount of Registration Fee 3.200% Senior Notes due 2031 $800,000,000 98.940% $791,520,000 $86,354.83(1) Guarantee of 3.200% Senior Notes due 2031(2)
September 22, 2021	8-K	Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): September 21, 2021 SABRA HEALTH CARE REIT, INC. (Exact Name of Registrant as Specified in Its Charter) Maryland 001-34950 27-2560479 (State of Incorporation) (Commission File Number)
September 22, 2021	EX-1.1	Underwriting Agreement, dated September 21, 2021, by and among Sabra Health Care REIT, Inc., Sabra Health Care Limited Partnership, and Wells Fargo Securities, LLC, BofA Securities, Inc., Credit Agricole Securities (USA) Inc. and J.P. Morgan Securities LLC, as representatives of the several underwriters named therein. Exhibit 1.1 EXECUTION VERSION Sabra Health Care REIT, Inc. Sabra Health Care Limited Partnership $800,000,000 3.200% Senior Notes due 2031 UNDERWRITING AGREEMENT September 21, 2021 Wells Fargo Securities, LLC BofA Securities, Inc. Credit Agricole Securities (USA) Inc. J.P. Morgan Securities LLC As Representatives of the several Underwriters Wells Fargo Securities, LLC 550 South Tryon Street, 5th F
September 21, 2021	FWP	Final Term Sheet Sabra Health Care Limited Partnership 3.200% Senior Notes due 2031 September 21, 2021 Filed Pursuant to Rule 433 Issuer Free Writing Prospectus to Preliminary Prospectus Supplement dated September 21, 2021 and Registration Statement No.
September 21, 2021	424B5	SUBJECT TO COMPLETION, DATED SEPTEMBER 21, 2021 Table of Contents Filed Pursuant to Rule 424(b)(5) Registration No. 333-235449 The information in this preliminary prospectus supplement is not complete and may be changed. SUBJECT TO COMPLETION, DATED SEPTEMBER 21, 2021 PROSPECTUS SUPPLEMENT (to Prospectus dated December 11, 2019) $ Sabra Health Care Limited Partnership % Senior Notes due 2031 Sabra Health Care Limited Partnership (the ?Operating
September 13, 2021	EX-99.2	What Happens Inside Our Buildings Matters Most BMO 2021 Real Estate Conference \| September 14, 2021 Forward-Looking Statements This presentation contains “forward-looking” statements, as defined in the Private Securities Litigation Reform Act of 1995 What Happens Inside Our Buildings Matters Most BMO 2021 Real Estate Conference \| September 14, 2021 Forward-Looking Statements This presentation contains ?forward-looking? statements, as defined in the Private Securities Litigation Reform Act of 1995, that may be identified, without limitation, by the use of ?expects,? ?believes,? ?intends,? ?should? or comparable terms or the negative thereof.
September 13, 2021	8-K	Regulation FD Disclosure, Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): September 13, 2021 SABRA HEALTH CARE REIT, INC. (Exact name of registrant as specified in its charter) Maryland 001-34950 27-2560479 (State of Incorporation) (Commission File Number)
September 13, 2021	EX-99.1	Sabra Health Care REIT, Inc. Announces a Proposed Agreement to Expand Relationship with Recovery Centers of America; Provides Business Update; Reaffirms 2021 Outlook Sabra Health Care REIT, Inc. Announces a Proposed Agreement to Expand Relationship with Recovery Centers of America; Provides Business Update; Reaffirms 2021 Outlook IRVINE, CA (BUSINESSWIRE) Sabra Health Care REIT, Inc. (?Sabra,? the ?Company? or ?we?) (Nasdaq: SBRA) today announced it intends to enter into an agreement to expand its relationship with Recovery Centers of America (?RCA?) and provi
August 6, 2021	424B5	CALCULATION OF REGISTRATION FEE Title of Each Class of Securities to be Registered Proposed Maximum Aggregate Offering Price Amount of Registration Fee(1)(2) Common Stock, par value $0.01 per share $500,000,000 $44,712.79 Table of Contents Filed Pursuant to Rule 424(b)(5) Registration No. 333-235449 CALCULATION OF REGISTRATION FEE Title of Each Class of Securities to be Registered Proposed Maximum Aggregate Offering Price Amount of Registration Fee(1)(2) Common Stock, par value $0.01 per share $500,000,000 $44,712.79 (1) The registration fee related to shares of common stock having an aggregate offering price of $5
August 6, 2021	EX-1.1	Equity Distribution Agreement, dated August 6, 2021, among the Company, the Sales Agents party thereto, and the Forward Purchasers party thereto (incorporated by reference to Exhibit 1.1 of the Current Report on Form 8-K filed by Sabra Health Care REIT, Inc. on August 6, 2021). EX-1.1 2 d16284dex11.htm EX-1.1 Exhibit 1.1 EXECUTION VERSION SABRA HEALTH CARE REIT, INC. $500,000,000 of Shares of Common Stock (par value $0.01 per share) Equity Distribution Agreement August 6, 2021 Barclays Capital Inc. 745 Seventh Avenue New York, New York 10019 BMO Capital Markets Corp. 3 Times Square, 25th Floor New York, New York 10036 BNP Paribas Securities Corp. 787 7th Avenue, 8th Floo
August 6, 2021	10-K/A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1) (Mark One) ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number 001-34950 SABRA HEALTH CARE REIT, INC.
August 6, 2021	8-K	Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 6, 2021 SABRA HEALTH CARE REIT, INC. (Exact Name of Registrant as Specified in Its Charter) Maryland 001-34950 27-2560479 (State of Incorporation) (Commission File Number) (I.R
August 4, 2021	EX-99.1	SABRA HEALTH CARE REIT, INC. CONDENSED CONSOLIDATED STATEMENTS OF (LOSS) INCOME (dollars in thousands, except per share data) Three Months Ended June 30, Six Months Ended June 30, 2021 2020 2021 2020 Revenues: Rental and related revenues $ 110,783 $ EX-99.1 2 sbraex9912021q2.htm Q2 2021 EARNINGS RELEASE Exhibit 99.1 FOR IMMEDIATE RELEASE SABRA REPORTS SECOND QUARTER 2021 RESULTS; ANNOUNCES INTENT TO EXIT ITS ENLIVANT JOINT VENTURE INVESTMENT; PROVIDES BUSINESS UPDATE AND 2021 GUIDANCE IRVINE, CA, August 4, 2021 — Sabra Health Care REIT, Inc. (“Sabra,” the “Company” or “we”) (Nasdaq: SBRA) today announced results of operations for the second q
August 4, 2021	EX-99.4	Sabra Health Care REIT, Inc. Announces Chief Financial Officer Transition Exhibit 99.4 Sabra Health Care REIT, Inc. Announces Chief Financial Officer Transition IRVINE, CA (BUSINESSWIRE) Sabra Health Care REIT, Inc. (?Sabra,? the ?Company? or ?we?) (Nasdaq: SBRA) today announced that Harold Andrews, Sabra?s Executive Vice President, Chief Financial Officer and Secretary, has decided to retire effective December 31, 2021 and Michael Costa, Sabra?s Executive Vice Presiden
August 4, 2021	EX-99.3	Reconciliations of Non-GAAP Financial Measures June 30, 2021 SABRA HEALTH CARE REIT, INC. 2021 OUTLOOK Reconciliations of Non-GAAP Financial Measures June 30, 2021 (Unaudited) SABRA HEALTH CARE REIT, INC.
August 4, 2021	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001
August 4, 2021	8-K	Regulation FD Disclosure, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 4, 2021 SABRA HEALTH CARE REIT, INC. (Exact name of registrant as specified in its charter) Maryland 001-34950 27-2560479 (State of Incorporation) (Commission File Number) (I.R
August 4, 2021	EX-99.2	Exhibit 99.2 2 SABRA 2Q 2021 SUPPLEMENTAL INFORMATION June 30, 2021 03 COMPANY INFORMATION 04 OVERVIEW 05 PORTFOLIO Triple-Net Portfolio Same Store Triple-Net Portfolio Top 10 Relationships and COVID-19 Mitigation Summary Senior Housing - Managed Por EX-99.2 3 sbraex9922021q2.htm Q2 2021 SUPPLEMENTAL INFORMATION Exhibit 99.2 2 SABRA 2Q 2021 SUPPLEMENTAL INFORMATION June 30, 2021 03 COMPANY INFORMATION 04 OVERVIEW 05 PORTFOLIO Triple-Net Portfolio Same Store Triple-Net Portfolio Top 10 Relationships and COVID-19 Mitigation Summary Senior Housing - Managed Portfolio Loans and Other Investments \| Development Pipeline NOI Concentrations Geographic
July 29, 2021	CORRESP	* * * July 29, 2021 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance Office of Real Estate & Construction 100 F Street, N.
July 13, 2021	EX-99.1	Virtual Non-Deal Roadshow Hosted by JMP 1July 13, 2021 Strong. Resilient. Growing. Virtual Non-Deal Roadshow Hosted by JMP July 13, 2021 Our vast industry knowledge, experienced executive team and entrepreneurial spirit make Sabra uniquely positioned Virtual Non-Deal Roadshow Hosted by JMP 1July 13, 2021 Strong. Resilient. Growing. Virtual Non-Deal Roadshow Hosted by JMP July 13, 2021 Our vast industry knowledge, experienced executive team and entrepreneurial spirit make Sabra uniquely positioned to succeed in our dynamic industry. We have the size, know-how, balance sheet and passion to deliver long-term value to shareholders. DELIVERING VALU
July 13, 2021	8-K	Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): July 13, 2021 SABRA HEALTH CARE REIT, INC. (Exact name of registrant as specified in its charter) Maryland 001-34950 27-2560479 (State of Incorporation) (Commission File Number) (I.R.
June 17, 2021	8-K	Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 16, 2021 SABRA HEALTH CARE REIT, INC. (Exact name of registrant as specified in its charter) Maryland 001-34950 27-2560479 (State of Incorporation) (Commission File Number) (I.R.
June 17, 2021	EX-3.1	Amended and Restated Bylaws of Sabra Health Care REIT, Inc. SABRA HEALTH CARE REIT, INC. AMENDED AND RESTATED BYLAWS (As Adopted on June 16, 2021) ARTICLE I OFFICES Section 1. PRINCIPAL OFFICE. The principal office of the Corporation in the State of Maryland shall be located at such place as the Board of Directors may designate. Section 2. ADDITIONAL OFFICES. The Corporation may have additional offices, including a principal executive office, at such place
June 9, 2021	EX-99.1	Nareit's REITweek Virtual Investor Conference 1June 8-10, 2021 Strong. Resilient. Growing. Nareit’s REITweek Virtual Investor Conference June 8-10, 2021 Our vast industry knowledge, experienced executive team and entrepreneurial spirit make Sabra uni Nareit's REITweek Virtual Investor Conference 1June 8-10, 2021 Strong. Resilient. Growing. Nareit?s REITweek Virtual Investor Conference June 8-10, 2021 Our vast industry knowledge, experienced executive team and entrepreneurial spirit make Sabra uniquely positioned to succeed in our dynamic industry. We have the size, know-how, balance sheet and passion to deliver long-term value to shareholders.
June 9, 2021	8-K	Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 9, 2021 SABRA HEALTH CARE REIT, INC. (Exact name of registrant as specified in its charter) Maryland 001-34950 27-2560479 (State of Incorporation) (Commission File Number) (I.R.S
June 8, 2021	EX-99.1	Nareit's REITweek Virtual Investor Conference 1June 8-10, 2021 Strong. Resilient. Growing. Nareit’s REITweek Virtual Investor Conference June 8-10, 2021 Our vast industry knowledge, experienced executive team and entrepreneurial spirit make Sabra uni Nareit's REITweek Virtual Investor Conference 1June 8-10, 2021 Strong. Resilient. Growing. Nareit?s REITweek Virtual Investor Conference June 8-10, 2021 Our vast industry knowledge, experienced executive team and entrepreneurial spirit make Sabra uniquely positioned to succeed in our dynamic industry. We have the size, know-how, balance sheet and passion to deliver long-term value to shareholders.
June 8, 2021	8-K	Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 8, 2021 SABRA HEALTH CARE REIT, INC. (Exact name of registrant as specified in its charter) Maryland 001-34950 27-2560479 (State of Incorporation) (Commission File Number) (I.R.S
May 19, 2021	EX-99.1	Non-Deal Roadshow hosted by BMO 1May 19, 2021 Strong. Resilient. Growing. Non-Deal Roadshow hosted by BMO May 19, 2021 Our vast industry knowledge, experienced executive team and entrepreneurial spirit make Sabra uniquely positioned to succeed in our Non-Deal Roadshow hosted by BMO 1May 19, 2021 Strong. Resilient. Growing. Non-Deal Roadshow hosted by BMO May 19, 2021 Our vast industry knowledge, experienced executive team and entrepreneurial spirit make Sabra uniquely positioned to succeed in our dynamic industry. We have the size, know-how, balance sheet and passion to deliver long-term value to shareholders. DELIVERING VALUE Non-Deal Roadsho
May 19, 2021	8-K	Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 19, 2021 SABRA HEALTH CARE REIT, INC. (Exact name of registrant as specified in its charter) Maryland 001-34950 27-2560479 (State of Incorporation) (Commission File Number) (I.R.S
May 7, 2021	EX-99.1	MATERIAL U.S. FEDERAL INCOME TAX CONSIDERATIONS Exhibit 99.1 MATERIAL U.S. FEDERAL INCOME TAX CONSIDERATIONS This section summarizes the material U.S. federal income tax considerations associated with an investment in our common stock. This summary does not purport to consider all aspects of U.S. federal income taxation that might be relevant to holders of shares of our common stock. The summary is based on the Code, final, temporary and propos
May 7, 2021	8-K	Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 7, 2021 SABRA HEALTH CARE REIT, INC. (Exact Name of Registrant as Specified in Its Charter) Maryland 001-34950 27-2560479 (State of Incorporation) (Commission File Number) (I.R.S.
May 7, 2021	EX-99.2	Legal Matters Exhibit 99.2 Legal Matters Unless otherwise indicated in the applicable prospectus supplement, certain legal matters regarding the validity of the securities offered hereby will be passed upon for us by O?Melveny & Myers LLP, Newport Beach, California. Certain legal matters regarding Maryland law will be passed upon for us by Venable LLP, Baltimore, Maryland. Certain U.S. federal income tax matter
May 7, 2021	EX-99.3	Legal Matters Exhibit 99.3 Legal Matters Certain legal matters in connection with the securities offered hereby will be passed upon for us by O?Melveny & Myers LLP, Newport Beach, California. Certain legal matters relating to Maryland law will be passed upon for us by Venable LLP, Baltimore, Maryland. Certain U.S. federal income tax matters will be passed upon for us by Hogan Lovells US LLP, Washington, D.C. Th
May 5, 2021	8-K	Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 5, 2021 SABRA HEALTH CARE REIT, INC. (Exact name of registrant as specified in its charter) Maryland 001-34950 27-2560479 (State of Incorporation) (Commission File Number) (I.R.S.
May 5, 2021	EX-99.3	Reconciliations of Non-GAAP Financial Measures March 31, 2021 SABRA HEALTH CARE REIT, INC. 2Q 2021 OUTLOOK EX-99.3 4 sbraex9932021q1.htm Q1 2021 NON-GAAP RECONCILIATIONS Reconciliations of Non-GAAP Financial Measures March 31, 2021 (Unaudited) SABRA HEALTH CARE REIT, INC. 2Q 2021 OUTLOOK The table below sets forth our 2Q 2021 guidance (per diluted common share): Low High Net income $ 0.13 $ 0.14 Add: Depreciation and amortization of real estate assets 0.21 0.21 Depreciation and amortization of real est
May 5, 2021	EX-99.1	SABRA HEALTH CARE REIT, INC. CONDENSED CONSOLIDATED STATEMENTS OF INCOME (dollars in thousands, except per share data) Three Months Ended March 31, 2021 2020 Revenues: Rental and related revenues $ 113,383 $ 106,512 Interest and other income 2,941 2, Exhibit 99.1 FOR IMMEDIATE RELEASE SABRA REPORTS FIRST QUARTER 2021 RESULTS; PROVIDES BUSINESS UPDATE AND 2Q 2021 GUIDANCE IRVINE, CA, May 5, 2021 ? Sabra Health Care REIT, Inc. (?Sabra,? the ?Company? or ?we?) (Nasdaq: SBRA) today announced results of operations for the first quarter of 2021 and provided a business update and guidance for the second quarter of 2021. FIRST QUARTER 2021 RESULTS AND
May 5, 2021	10-Q	Quarterly Report - 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 00
May 5, 2021	EX-99.2	Exhibit 99.2 2 SABRA 1Q 2021 SUPPLEMENTAL INFORMATION March 31, 2021 03 COMPANY INFORMATION 04 OVERVIEW 05 PORTFOLIO Triple-Net Portfolio Same Store Triple-Net Portfolio Top 10 Relationships and COVID-19 Mitigation Summary Senior Housing - Managed Po Exhibit 99.2 2 SABRA 1Q 2021 SUPPLEMENTAL INFORMATION March 31, 2021 03 COMPANY INFORMATION 04 OVERVIEW 05 PORTFOLIO Triple-Net Portfolio Same Store Triple-Net Portfolio Top 10 Relationships and COVID-19 Mitigation Summary Senior Housing - Managed Portfolio Same Store Senior Housing - Managed Portfolio Loans and Other Investments \| Development Pipeline NOI Concentrations Geographic Concentrations
April 26, 2021	DEFA14A	- DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Defin
April 26, 2021	DEF 14A	Schedule 14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14
April 6, 2021	8-K	Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): April 6, 2021 SABRA HEALTH CARE REIT, INC. (Exact name of registrant as specified in its charter) Maryland 001-34950 27-2560479 (State of Incorporation) (Commission File Number) (I.R.
April 6, 2021	EX-99.1	14/2/2021 Strong. Resilient. Growing. 2nd Annual Mizuho Healthcare REIT Conference April 6, 2021 Our vast industry knowledge, experienced executive team and entrepreneurial spirit make Sabra uniquely positioned to succeed in our dynamic industry. We 14/2/2021 Strong. Resilient. Growing. 2nd Annual Mizuho Healthcare REIT Conference April 6, 2021 Our vast industry knowledge, experienced executive team and entrepreneurial spirit make Sabra uniquely positioned to succeed in our dynamic industry. We have the size, know-how, balance sheet and passion to deliver long-term value to shareholders. DELIVERING VALUE 2nd Annual Mizuho Healthcare REIT Conf
March 8, 2021	EX-99.1	CONSISTENT STRATEGY. DELIBERATE EXECUTION. Citi Global Property CEO Conference March 8 - 11, 2021 Our vast industry knowledge, experienced executive team and entrepreneurial spirit make Sabra uniquely positioned to succeed in our dynamic industry. We CONSISTENT STRATEGY. DELIBERATE EXECUTION. Citi Global Property CEO Conference March 8 - 11, 2021 Our vast industry knowledge, experienced executive team and entrepreneurial spirit make Sabra uniquely positioned to succeed in our dynamic industry. We have the size, know-how, balance sheet and passion to deliver long-term value to shareholders. DELIVERING VALUE Citi Global Property CEO ConferenceMa
March 8, 2021	8-K	Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 8, 2021 SABRA HEALTH CARE REIT, INC. (Exact name of registrant as specified in its charter) Maryland 001-34950 27-2560479 (State of Incorporation) (Commission File Number) (I.R.
February 24, 2021	8-K	Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 24, 2021 SABRA HEALTH CARE REIT, INC. (Exact name of registrant as specified in its charter) Maryland 001-34950 27-2560479 (State of Incorporation) (Commission File Number) (
February 24, 2021	EX-99.1	CONSISTENT STRATEGY. DELIBERATE EXECUTION. Wells Fargo Real Estate Securities Conference February 24, 2021 Our vast industry knowledge, experienced executive team and entrepreneurial spirit make Sabra uniquely positioned to succeed in our dynamic ind CONSISTENT STRATEGY. DELIBERATE EXECUTION. Wells Fargo Real Estate Securities Conference February 24, 2021 Our vast industry knowledge, experienced executive team and entrepreneurial spirit make Sabra uniquely positioned to succeed in our dynamic industry. We have the size, know-how, balance sheet and passion to deliver long-term value to shareholders. DELIVERING VALUE Wells Fargo Real Estate Secu
February 22, 2021	EX-99.2	Exhibit 99.2 2 SABRA 4Q 2020 SUPPLEMENTAL INFORMATION December 31, 2020 03 COMPANY INFORMATION 04 OVERVIEW 05 PORTFOLIO Triple-Net Portfolio Same Store Triple-Net Portfolio Top 10 Relationships and COVID-19 Mitigation Summary Senior Housing - Managed EX-99.2 3 sbraex9922020q4-final.htm Q4 2020 SUPPLEMENTAL INFORMATION Exhibit 99.2 2 SABRA 4Q 2020 SUPPLEMENTAL INFORMATION December 31, 2020 03 COMPANY INFORMATION 04 OVERVIEW 05 PORTFOLIO Triple-Net Portfolio Same Store Triple-Net Portfolio Top 10 Relationships and COVID-19 Mitigation Summary Senior Housing - Managed Portfolio Same Store Senior Housing - Managed Portfolio Loans and Other Investme
February 22, 2021	EX-99.3	Reconciliations of Non-GAAP Financial Measures December 31, 2020 SABRA HEALTH CARE REIT, INC. RECONCILIATIONS OF NON-GAAP FINANCIAL MEASURES FFO, Normalized FFO, AFFO and Normalized AFFO (dollars in thousands, except per share data) Three Months Ende EX-99.3 4 sbraex9932020q4.htm Q4 2020 NON-GAAP RECONCILIATIONS Reconciliations of Non-GAAP Financial Measures December 31, 2020 (Unaudited) SABRA HEALTH CARE REIT, INC. RECONCILIATIONS OF NON-GAAP FINANCIAL MEASURES FFO, Normalized FFO, AFFO and Normalized AFFO (dollars in thousands, except per share data) Three Months Ended December 31, Year Ended December 31, 2020 2019 2020 2019 Net income attri
February 22, 2021	EX-4.1	Description of Sabra Health Care REIT, Inc.’s Capital Stock DESCRIPTION OF CAPITAL STOCK OF SABRA HEALTH CARE REIT, INC. The following is a summary of the material terms of our capital stock as set forth in our Articles of Amendment and Restatement (our ?charter) and our Amended and Restated Bylaws (our ?bylaws?), which govern the rights of holders of our capital stock. The following summary does not purport to be complete and is subject to and qualified i
February 22, 2021	EX-10.11	Equity Distribution Agreement, dated December 11, 2019, among the Company, the Sales Agents party thereto, and the Forward Purchasers party thereto. EXECUTION VERSION [[5258451]] SABRA HEALTH CARE REIT, INC. $400,000,000 of Shares of Common Stock (par value $0.01 per share) Equity Distribution Agreement December 11, 2019 Barclays Capital Inc. 745 Seventh Avenue New York, New York 10019 BMO Capital Markets Corp. 3 Times Square, 25th Floor New York, New York 10036 BofA Securities, Inc. One Bryant Park New York, New York 10036 Citigroup Global Ma
February 22, 2021	10-K	Annual Report - 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number 001-34950 SABRA HEALTH CARE REIT, INC. (Exact Name of Regis
February 22, 2021	EX-99.1	SABRA HEALTH CARE REIT, INC. CONSOLIDATED STATEMENTS OF INCOME (dollars in thousands, except per share data) Three Months Ended December 31, Year Ended December 31, 2020 2019 2020 2019 Revenues: Rental and related revenues $ 110,733 $ 112,847 $ 430,5 Exhibit 99.1 FOR IMMEDIATE RELEASE SABRA REPORTS FOURTH QUARTER 2020 RESULTS; PROVIDES BUSINESS UPDATE AND 1Q 2021 GUIDANCE IRVINE, CA, February 22, 2021 ? Sabra Health Care REIT, Inc. (?Sabra,? the ?Company? or ?we?) (Nasdaq: SBRA) today announced results of operations for the fourth quarter of 2020 and provided a business update and guidance for the first quarter of 2021. FOURTH QUARTER 2020 RES
February 22, 2021	8-K	Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 22, 2021 SABRA HEALTH CARE REIT, INC. (Exact name of registrant as specified in its charter) Maryland 001-34950 27-2560479 (State of Incorporation) (Commission File Number) (
February 22, 2021	EX-10.8.3	Form of Notice and Terms and Conditions of Stock Unit Award (TSR Units) (for Executive Officers), adopted December 2020 (incorporated by reference to Exhibit 10.8.3 of the Annual Report on Form 10-K filed by Sabra Health Care REIT, Inc. on February 22, 2021). NOTICE OF STOCK UNIT GRANT SABRA HEALTH CARE REIT, INC. 2009 PERFORMANCE INCENTIVE PLAN Name of Grantee: [?] Target Number of Stock Units: [?] Date of Grant: [?] Vesting: In general, and with limited exceptions set forth below, your units are subject to two different vesting requirements. The first requirement is a total shareholder return-based requirement. To the extent it is satisfied, your uni
February 22, 2021	EX-21.1	List of Subsidiaries of Sabra Health Care REIT, Inc. Exhibit 21.1 Sabra Subsidiaries Entity Name Jurisdiction of Organization 1717 Senior Partners, LLC (Subsidiary of Joint Venture) Indiana 2100 Benvoulin Court Holdings, Inc. British Columbia 2829-34th Street Holdings, Inc. British Columbia 317 Winnipeg St. Holdings Inc. British Columbia 3211 Alexis Park Drive Holdings Inc. British Columbia 870 Westminster Ave. Holdings, Inc. British Columbia Arden
February 22, 2021	EX-10.10	Severance Benefits Agreement, dated November 22, 2010, by and between Sabra Health Care REIT, Inc. and Michael Costa.
February 10, 2021	SC 13G/A	SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 11)* SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 11)* Name of issuer: Sabra Health Care REIT Inc. Title of Class of Securities: REIT CUSIP Number: 78573L106 Date of Event Which Requires Filing of this Statement: December 31, 2020 Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
January 19, 2021	EX-99.1	CONSISTENT STRATEGY. DELIBERATE EXECUTION. Stifel 2021 Seniors Housing and Healthcare Real Estate Conference January 19, 2021 Our vast industry knowledge, experienced executive team and entrepreneurial spirit make Sabra uniquely positioned to succeed stifeljan2021 CONSISTENT STRATEGY. DELIBERATE EXECUTION. Stifel 2021 Seniors Housing and Healthcare Real Estate Conference January 19, 2021 Our vast industry knowledge, experienced executive team and entrepreneurial spirit make Sabra uniquely positioned to succeed in our dynamic industry. We have the size, know-how, balance sheet and passion to deliver long-term value to shareholders. DELIVERING V
January 19, 2021	8-K	Regulation FD Disclosure, Financial Statements and Exhibits - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 19, 2021 SABRA HEALTH CARE REIT, INC. (Exact name of registrant as specified in its charter) Maryland 001-34950 27-2560479 (State of Incorporation) (Commission File Number) (I
January 12, 2021	8-K	Regulation FD Disclosure, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 11, 2021 SABRA HEALTH CARE REIT, INC. (Exact name of registrant as specified in its charter) Maryland 001-34950 27-2560479 (State of Incorporation) (Commission File Number) (I

SBRA / Sabra Health Care REIT, Inc. - Pengajuan SECLaporan Tahunan, Pernyataan Proksi

Mga Batayang Estadistika

SEC Filings

SEC Filings (Chronological Order)

Other Listings

MX:SBRA
DE:SBC	€ 16.16